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The chemical synthesis of sulfate and phosphate derivatives of galactose-p-1,4- 
7V^acetylglucosamine-OR (octyl iV-acetyllactosamine) and galactose-p-l,3-A- 
acetylglucosamine-OR [where R= are reported here using N-
acetylglucosamine and galactose as starting materials. Sialylation of octyl N- 
acetyllactosamine derivatives was achieved using ^r««5'-sialidase. These compounds 
were evaluated as potential acceptor substrates for five recombinant a-1,3- 
fiicosyltransferases (a-l,3-FucT) and a semi-pure a-l,3/4-FucT (human milk). The 
kinetic data showed a wide range of acceptor specificities between different 
recombinant enzymes. Octyl iV^acetyllactosamine 6-0-sulfate proved to be an excellent 
substrate for a-l,3-FucT VI, with a of 0.85 pM. This substrate has a lower than 
any reported substrate for any a-l,3-FucT. An unusual result was observed for octyl N- 
acetyllactosamine derivatives containing a sulfate or phosphate group at the site of 
glycosylation. These compounds were found to be good acceptor substrates for a-1,3- 
FucT VI and miUc a-l,3/4-FucT with and values similar to those of the parent 
compound, octyl 7V-acetyllactosamine. Preliminary studies show that the product of such 
a reaction could contain a sulfate or phosphate diester linkage between fixcose and octyl 
LacNAc. If the anionic substituent at the site of glycosylation is being fucosylated, 
current models proposed for a mechanism involving an enzyme active site base 
mechanism cannot explain this result. An alternative mechanism has been suggested 
involving Mn^  ^ coordination to the hydroxyl group of the acceptor substrate being 
glycosylated. This mechanism can also be used to explain the unusual kinetic results 
obtained for substrates containing a sulfate or phosphate group at the site of 
glycosylation.
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AgOTf silver trifluoromethane
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NIS V-iodosuccinimide
jP-TsOH /7ara-toluenesulfonic acid
py pyridine
t.l.c. thin layer chromatography
TFA trifluoroacetic acid
TfDH trifluoromethanoic acid
THF tetrahydrofuran
TMSOTf trimethylsilyl triflate 
TOF time of flight detector
TRIS tris-hydroxymethyl-
aminomethane
Carbohydrate Abbreviations
octyl
LacNAc Gal-p-l,4-GlcNAc
GlcNAc 2-acetamido-2-deoxy-D-glucopyranose
Gal D-galactose
Fuc L-fucose
GDP guanosine diphosphate
UDP uridine diphosphate
Le" Gal-p-l,3-GlcNAc
Le" Gal-P-l,4-(a-l,3-Fuc)-GlcNAc
sialyl Le"" NeuAc-a-2,3“Gal-p-1,4-(a-1,3-Fuc)-GlcNAc
a-l,3-FucT a - 1,3-fucosyltransferase
p-l,4-GalT p-1,4-galactosyltransferase
NeuAc sialic acid, 5-acetamido-3,5-dideoxy-D-g/ycero-a-D-ga/ac?o-non-2-
ulopyranosyl

It is now widely accepted that carbohydrates are involved in a diverse array of 
functions in all living systems, in addition to the energy storage (e.g. starch / glycogen) and 
structural roles (e.g. cellulose / chitin) classically assigned to them. In recent years much 
interest has focused on glycoconjugates (carbohydrate molecules attached to proteins or 
lipids) which are involved in mediating ‘specific recognition’ events and ‘modulating’ 
biological processes. Consequently oligosaccharides help to generate the diversity of 
functions required to develop different cell-types, tissues, organs and species (for review 
see [1]).
Glycoconjugates are major components of cell surfaces and are often characteristic 
of cell-type. It is assumed that these cell type-specific saccharides are involved in cellular 
processes such as antigen binding and seiwing as ligands in cell-cell interactions [1]. As a 
result carbohydrates have been found to be important in cell recognition processes, cell 
growth and cell defense, including roles such as binding of bacterial and viral antigens on 
mammalian cells, bacterial toxins, blood group determinants and cell-cell recognition 
processes. Perhaps of more interest is the fiinction of carbohydrates in disease states such as 
metastasis of cancer, inflammatory responses and bacterial infection. Hence in recent years 
there has been a growing interest in the development of carbohydrate based drugs within 
the pharmaceutical industry [2]. \
Some examples of naturally occurring oligosaccharides and their biological 
functions are described in the following sections.
Every organism has a wide variety of glycans which may either be linlced to lipids 
(glycolipids) or proteins (glycoproteins or proteoglycans) or may occur as free 
carbohydrates.
1.2.1 Glycoproteins
Glycoproteins are divided into two main classes depending on their linlcage to the 
protein. 7V-Linlced glycoproteins are oligosaccharides which are attached to the side chain of 
an asparagine residue whereas O-linlced glycoproteins have carbohydrates attached to the 
side chain of serine or threonine.
L2.L1 N4inked Gfycoproteins
There are three main classes of iV-glycans, high mannose, complex and hybrid. All 
are derived from a common trimannosyl core Man-a-1,6-(Man-a-1,3)-Man-p-1,4-GlcNAc- 
p-1,4-GlcNAc-Asn (Figure 1.1). The outer branches differ among the different subtypes 
(for general information see [3]).
+/-{Mana1 -2)o-2lViana1 '
;+/-NeuAGa2-3(6)Galp1-4GlcNAcpi“)i-2t^ana1.
+/-Mana1 -2Mana1 \ 6 Manal s.^ 3  6
+/-Mana1-2Mana1 ^Manpi-4GlcNAcp1-4GlcNAcp-Asn
High Mannose Type
‘6Manpi -4GlcNAcpi -4GlcNAcP-Asn
[+/-NeuAca2-3(6)Gaipi-4GlcNAcpi-)i-2Mana1
Complex Type
+/-Mana1“2Mana1
6 Manat -  ^ 3  6
+/-Mana1-2Mana1  ^Manpi-4GlcNAcpi-4GlcNAcp-Asn
[+/-NeuAca2-3(6)Galp1-4GlcNAcpi“)i-2Mana1‘
Hybrid Type
Figure 1.1: High Mannose, Complex and Hybrid Type A^Glycans
The biosynthesis of the iV-glycan core is initiated by transfer of a large 
oligosaccharide, Glc^MangGlcNAc^ from dolichol pyrophosphate to an asparagine residue 
of a protein. Oligosaccharide processing of these glycans begins with removal of three 
glucose residues. A series of reactions then proceed until the chain is capped thus forming 
the three different glycan subtypes. The complex and hybrid type glycans have a terminal 
unit Gal-p-1,4-GlcNAc which is the core of Lewis x and y antigens. The most common 
residue capping this sequence is sialic acid (NeuAc) giving sialylated Lewis antigens, for 
example sialyl Lewis x (Section 1.3).
1,2J,2 O-Lmked Giymm
The O-linked glycans have the reducing terminus of an oligosaccharide linlced to the 
hydroxyl side chain of serine or threonine. This class can be further sub-divided into three 
main groups depending on the type of sugar and amino acid residues involved in the 
linkage. The first group aie the mucin type 0-glycans which contain an N- 
acetylgalactosamine residue linked to a serine or threonine linlcage. The second group also 
have a sugar- linlced to a serine or threonine residue but the sugar is A-acetylglucosamine 
(O-GlcNAc type).
Unlike V-glycans the family of O-glycans do not share a common core structure, 
there are in fact at least four core types (reviewed [3]). Thus the biosynthesis of 0-glycans 
is more diverse than that for the corresponding V-glycans. The 0-glycan chain is built up 
by successive addition of hexose or hexosamine units. Termination of the chain is achieved 
by sialylation and there are thought to be four* different sialyltransferase enzymes involved 
in this process. An example of an O-linked glycan is the glycoprotein GlyCAM-1 
(glycosylation-dependent cell-adhesion molecule) which is part of a ligand for a protein L- 
selectin which is involved in inflammation.
1,2J 3  Gfycosmnm&glycam
The third main class of glycoproteins are the proteoglycans which have a xylose 
residue attached to a serine or threonine unit. One type of proteoglycan is 
glycosylaminoglycans (GAGs). There are seven known classes of GAGs (Figure 1.2). 
These are unbranched repeating disaccharide units which are often found covalently 
attached to proteins forming proteoglycan type structures. The most commonly found
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GAGs are chondroitin-4-sulfate, chondroitin-6-sulfate, dermatan sulfate and heparan 
sulfate. Heparin is another highly sulfated GAG which is synthesized as part of a 
proteoglycan but is more commonly found as free carbohydrate. Keratan sulfate is typically 
found in connective tissues. The seventh class of GAG, hyaluronan, is synthesized 
independently of a protein backbone and contains no sulfation. It has the simplest structure 
containing only repeating disaccharides of glucuronic acid and A-acetylglucosamine in 
alternating P-1,3 and P-1,4 linkages.
pH PH
HO HO
OH NHAc OH NHAc
Hyaluronan Chondroitin-4-su!fate
PHHO000*
HO HO
OH NHAc NHAc
Dermatan SulfateChondroitin-6-sulfate
PSO3-
HOOH NHAc
Keratan Sulfate
COO*HO
AcHN
HO OH
HO
Heparin / Heparan Sulfate
Figure 1.2; Giycosaminoglycan Structures
GAGs are known to play an important structural role on the surface of many cell 
types [4], however, they are also thought to be important in other processes. For example, it
is known that heparin has anticoagulant activity and in fact is used as a prophylactic in the 
clinical treatment of thrombosis [5].
1.2.2 Glycolipids
Carbohydrates linked to lipids embedded in the cell membrane can be divided into 
two groups. The most commonly found glycolipid, glycosphingolipids, have a ceramide 
unit attached through a p-linlced lactosyl carbohydrate moiety (Figure 1.3) (Section 
1.2.2.1). The second class of glycolipids, glycosyl phosphatidyl inositols (GPI), have a 
phosphoglycerol unit attached to the carbohydrate chain and form part of a linldng arm for 
the attachment of proteins to membranes (Section 1.2.2.2).
.OHOH .OH
HN
HO
HOOH OH
OH
R = long chain alkyl group
Fignre 1.3: Lactosyl-Ceramide Linkage Fonnd in Glycolipids.
1.2,2.1 Glycosphingolipids,
Glycosphingolipids (GSL) are components of eukaryotic cell membranes and can be 
classified into four major groups according to their core structure (Table 1-1) [6].
Gangliosides Gal-p-1,3-GalNAc-p-1,4-Gal-P-1,4-Glc-P-1,1 -Cer
Globosides GalNAc-P" 1,3-Gal-ot-l ,4-Gal“P-1,4-Glc-P-1,1 -Cer
Lactosides (type I) Gal-p-l,3-GlcNAc-P-l,3-Gal-P-l,4-Glc-P-l,l-Cer
Lactosides (type II) Gal-p-l,4-GlcNAc-P-.l,3-Gal-p-l,4-Glc-p-l,l-Cer
Table 1-1 Classification of Glycosphingolipids
Most GSLs contain an acidic monosaccharide group, for example, glucuronic acid, 
galacturonic acid or sialic acid. In some GSLs the essential core structure may be branched
or some of the sugar residues may contain sulfate groups, for example sulfoglucuronyl 
glycolipids (SGGL) which are found in peripheral nerves (Figure 1.4) [7].
COOH O H ^ O H .OH o h .OH
H O '—
HO3SO*.A ---— ^  h o 2 0 -ceramide
OH OH AcNH OH OH
Figure 1.4: Structure off SGGL Glycolipid.
1.2,2,2 GPI Anchors
Glycosyl phosphatidyl inositol (GPI) containing glycoproteins are ubiquitous in 
nature (for review articles see [8], [9]). The oligosaccharide chain is linked to phosphatidyl 
inositol, which is capable of inserting into the cell - surface lipid bilayer. The non-reducing 
terminus of the oligosaccharide is linlced to the C-terminal carbonyl group of a protein 
through a phosphoethanolamine unit. The GPI anchor therefore serves as a functional 
alternative to a membrane spanning peptide domain in the attachment of proteins to the cell 
surface. The first GPI anchor structure to be determined was that of the variant surface 
glycoprotein of the A&ican trypanosome, Trypanosoma brucei (Figure 1.5). This par asite, 
which causes sleeping siclcness, uses its dense GPI - anchored protein coat to evade the 
immune response of the infected host.
Protein — A s n C = o
NH-CH2 CH2 O
0 = P —O'Io
Mana1-2Mana1-6Mana1-4GlcNH 2a 1-6 lno-1 — PO4 CH2 CH-CH2
+/-Gala1 -2Gala1 -6Gala1 -3 
+/-Gala1 -2
0 O1 I0 = C  0 = 0I I
14<H2C) (C H 2 ) i 4 
CH3 CH3
Figure 1.5; The Structure off the GPI-anchor Variant Surface Glycoprotein Found in
Trypanosoma brucei
1.2»2,3 Lipop&tysaccharides
Lipopolysaccharides (LPS) are released by Gram negative bacteria and are 
responsible for the toxic effects observed during bacterial infections. The lipid component 
of LPS’s (Lipid A) is embedded in the outer membrane of bacterial cells. Attached to the 
lipid is a polysaccharide which protrudes into the environment and is composed of two 
distinct sections. The core section is made up of two sugar rings (commonly N- 
acetylglucosamine residues modified by phosphate gioups, Figure 1.6) and is attached 
directly to the lipid component. The second section is a longer chain usually made up of 
repeating units of three to eight sugars. Linking the core and outer sections are two unusual 
sugars, a heptose unit (seven carbon sugar) and Kdo (3-deoxy-D-manno-2-octulosonic 
acid). Kdo is an eight carbon sugar and occurs nowhere else in nature. It is the terminal 
disaccharide phospholipid (Figure 1.6: Lipid A) which has been shown to be responsible 
for toxic activity. In humans acute inflammatory responses to lipid A results in the release 
of cytokines and other cellular mediators such as tumor necrosis factor a  (TNF-a) and 
interleuldn-1 (IL-1). It is these cellular mediators which result in the physical disorders 
associated with infection [10], [11].
HO^  
HO— P, OH
NH
OH
o= HO
NH
OH OH
Figure 1.6: The Lipid A Section From Escherichia eoli
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L3 The Lewis Antigem
Every organism contains a wide variety of glycoconjugates which may be linlced to 
lipids or iV-linlced or O-linked to proteins. These glycoconjugates are typical for the 
organism and the tissue type. An example of cell-type specific oligosaccharides are the 
Lewis antigens. These oligosaccharides ‘decorate’ mammalian cells and can be found 
attached to lipids or more commonly TV-linked to proteins. They are involved in many 
biological processes and have similar stmctures, biosynthetic pathways and fimctions in the 
human body [3]. There are four laiown Lewis antigens, Lewis a (Le^), Lewis b (Le'’), Lewis 
X (Le’‘) and Lewis y (Le^ (Figure 1.7).
HO HOOH OH
OH OH
OH ^ O H OH OH
HO OR HO OR
NHAcOH NHAc
Le‘
OH
OHOH
HO HOOH OH
OH OH
OH OHNHAc NHAc
OR ORHO HO
OH
OH OHLe’
OH
OHOH
Figure 1.7; The Lewis a, b, x and y Antigens 
R = glycoprotein or glycolipid
The Lewis a and b oligosaccharides have a type I core derived from Gal-p-1,3- 
GlcNAc. The core of Lewis antigens x and y are type II chains containing Gal-p-1,4-
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GlcNAc (iV-acetyllactosamine). The core oligosaccharide may be capped with sialic acid 
residues forming sialylated Lewis antigens, for example sialyl Lewis x (Figure 1.8).
13,1 Biological Role of the Lewis Antigens
Due to the presence of Lewis antigens on the surface of cells, it is thought they may 
be involved in cell-cell interactions. The diversity of carbohydrate structures found on 
different cell surfaces may provide specific sites which are recognized by receptor 
molecules. Evidence to suggest that cell surface carbohydrates do act as ligands for 
receptors came fi'om the discovery of a group of carbohydrate binding proteins known as 
lectins. One family of adhesive lectin molecules found in eulcaryotic cells are selecting of 
which there are three types, L (leukocyte)-selectin, P (platelet)-selectin and E (endothelial)- 
selectin. These all have different fimctions and are present in different cell types. All the 
selecting are involved in adhesion between circulating leulcocytes and endothelium or 
platelets (for a general review see [3]). The adhesion of leulcocytes is dependent on 
carbohydrate-protein interactions. All of the Lewis antigens are involved in cell-cell 
interactions but for the purposes of this thesis it is the role of the antigen sialyl Lewis x 
(Figure 1.8) which is of interest.
HO OH
OH
NHAc
ORCO'^ ' O
OH
OH
OHOH
OHAcNH
HO
Figure 1.8: The Sialyl Lewis s  Antigen 
R = glycoprotein or glycolipid
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1.3.2 Sialyl Lewis x and its Role in Inflammatory Response
Under normal physiological conditions leukocytes (white blood cells) flow rapidly 
through the mammalian blood stream. In response to tissue damage a tetrasaccharide, sialyl 
Lewis X (sLe’^) is expressed on the surface of leukocytes. This carbohydrate interacts with a 
protein (E-selectin) present on the surface of the endothelium. The effect of this interaction 
is to slow the movement of leulcocytes through the blood vessels, eventually leading to a 
‘rolling’ effect. Firm attachment of the leulcocytes can eventually occur leading to 
extravasation of the leulcocytes into the damaged tissue (Figure 1.9) [12], [13], [14]. This 
process is part of the host’s self defense mechanism, without which it is more susceptible 
to, among other things, bacterial infections.
.^-^asement membrane
rolling activation firm adhesion
.endothelial cells
extravasation
Figure 1.9: luteracüom of Leukocytes with Eadothelial Cells.
However, there are a series of acute and chronic disorders such as rheumatoid arthritis, 
psoriasis and acute and chronic inflammation, during which too many leukocytes are 
recruited to the site of injury resulting in severe damage to tissue. Therapeutic intervention 
by interruption of the interaction of the sLe’^ antigen with E-selectin might be possible.
1.3.3 Sialyl Lewis x and Cancer.
It has been found that tumor cells, in particular leulcemia and carcinomas, have an 
increased concentration of iV-acetyllactosamine residues terminating in sLe'^ . The process of 
tumor formation is thought to be analogous to that of leukocyte recruitment during 
inflammatory responses. First the tumor cells flowing through the blood become attached to 
platelets. Similar to inflammation, this interaction of tumor cells with P-selectin is initiated
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by the tetrasaccharide sLe’'. These tumor aggregates can be trapped in veins resulting in a 
release of cytokines such as interleukin-1 from the tumor cell resulting in extravasation of 
the tumor cell into the tissue [15]. Once the tumor cells grow in beneath endothelial tissue 
tumor metastasis is established [16].
1.3.4 Inhibition of SLe'-Protein Interactions.
Sialyl Lewis x is obviously an important molecule in biological systems. Whilst 
being essential for the well being of the organism over-expression of this tetrasaccharide 
can have fatal consequences. Perhaps if the interaction of sLe’^ with carbohydrate - binding 
proteins could be interrupted, some of these unwanted physiological disorders could be 
prevented. One possible method for interrupting the carbohydrate-protein interactions 
described above involves synthesizing mimics of the sLe’^ antigen which would be 
recognized by the selectin, but which would prevent extravasation of the leukocyte into the 
damaged tissue. Work on this strategy is being carried out by a number of groups (see refs. 
[17] - [23]).
1.3.5 Biosynthesis off Sialyl Lewis x
An alternative strategy for altering the sLe’^ - E-selectin interaction during 
inflammatory response is to interrupt the biosynthetic pathway leading to sLe’^ formation. A 
method for achieving this is to inhibit the enzymes involved in the synthesis of sLe’^. Sialyl 
Lewis X is an a-2,3-linked sialylated tetrasaccharide which is structuially related to the Le* 
antigen (Figure 1,8). A cartoon of the biosynthetic pathway is shown in Figure 1.10. The 
first enzyme involved in the biosynthesis of sLe* is A-acetyglucosaminyltranserase which 
catalyzes the transfer of A-acetylglucosamine (GlcNAc) to the terminus of an A-glycan. 
The second step is transfer of a galactose residue fr om uridine diphosphate galactose (UDP- 
Gal) to the 4-OH of the GlcNAc residue, catalyzed by UDP-Gal: (3-1,4-
galactosyltransferase (p-l,4-GalT). A sialic acid unit is then transferred from cytosine 
monophoshate sialic acid (CMP-sialic acid) to the 3 position of the galactose unit, catalyzed 
by CMP-sialic acid: a-2,3-sialyltransferase (a-2,3-SialylT). The final step in the 
biosynthesis is fucosylation. The enzyme catalyzing this step is a -1,3-fucosyltransferase
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(a-i,3-FucT) and this results in transfer of a fucose residue from guanosine diphosphate 
fucose to the 3-OH of the GlcNAc moiety.
OROR
Gal
GlcNAc
OR
Gal GlcNAc
NeuAc
Fuc
OR
Gal GlcNAc
SLe
NeuAc
Figure 1,10; The Biosynthetic Pathway Leading to sLe'
R = glycoprotein
There are four key enzymes participating in the biosynthesis of the sLe’‘ antigen, 
thus there are four possible places to interrupt the biosynthetic pathway. Fucosylation is the 
final step in the biosynthetic pathway and would appear to be a good place to interrupt the 
biosynthesis with minimal effect on other biological processes.
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1.4 Glycosyl Group Transfer
The examples given in Section 1.2 and 1.3 demonstrate the importance of 
oligosaccharides within living systems and as potential therapeutic targets for the treatment 
of cancer, infectious diseases and inflammation. The biosynthesis of oligosaccharides 
present on the surface of mammalian cells is controlled by the action of two classes of 
enzymes, the glycosyl hydrolases (glycosidases) and the glycosyltransferases. The 
processes catalyzed by these two classes of enzymes are essentially the same. Both are 
involved in the cleavage of glycosidic linkages between the anomeric carbon of a sugar and 
an oligosaccharide or a nucleoside diphosphate group. The liberated sugar can then be 
transferred to water (glycosidases) or to another nucleophilic acceptor 
(glycosyltransferases).
1.4.1 Non-Enzymatic Glycosyl Group Transfer
Nucleophilic substitution at the anomeric carbon of sugars is dominated by the 
participation of the lone-pair of electrons on the ring oxygen. This results in formation of a 
glycosyl cation (oxocarbonium ion). Nucleophilic attack on this cation results in formation 
of a new glycosidic linkage (Figure 1.11) (reviewed by Sinnot [24]). Oxocarbonium ions of 
this type are also thought to play a part in the enzyme catalyzed glycosyl transfer reactions.
OR
L = leaving group 
R = H or alkyl / aryl / sugar
Figure 1.11: Non-Enzymatic Glycosyl Group Transfer
A review of methods for achieving chemical coupling of sugars can be found in 
Chapter 3.
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1.4.2 Glycoside Hydrolases
There are several types of glycosidases which have been defined based on their 
modes of action. Enzymes which cleave glycosidic bonds at the non-reducing end of an 
oligosaccharide are laiown as exoglycosidases, whereas endoglycosidases cleave internal 
glycosidic linkages along a polysaccharide chain. A further classification is made based on 
the overall stereochemical outcome of the reaction catalyzed by glycosidases. Cleavage by 
a retaining glycosidase results in conservation of the anomeric configuration in the product 
and the mechanism is thought to involve a double inversion, as proposed by Koshland in 
1953 (Figure 1.12) [24], [25].
H—O. 05-
HO,
Figure 1.12: Mechanism for Hydrolysis with Retention of Configuration
Enzymes catalyzing hydrolysis yielding an overall inversion of configuration at the 
anomeric centre of the product are thought to proceed via a single inversion step and are 
loiown as inverting glycosidases (Figure 1.13).
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Fîgmre 1.13: Proposed Mecisamism for Hydrolysis with Inversion off Configuration
L4,2ol Glycosidase Inhibitors
Specific inhibitors of glycosidases can yield information about the mechanism of 
the reaction and are also of therapeutic value, for example some act as antiviral agents by 
interrupting the biosynthesis of viral glycoproteins [26]. Many of the Imown inhibitors of 
glycosidases have structures which mimic the oxocarbenium ion transition state for 
glycoside hydrolysis. The first glycosidase inhibitors were monosaccharide derived ô- 
aldonolactones (e.g. D-gluconolactone) and glycosylamines (e.g. D-glucosamine) (Figure 
1.14) which showed competitive inhibition of the glycosidases whose substrates they most 
closely resembled. More recently polyhydroxylated piperidines (e.g. 1-deoxynojirimycin), 
pyrrolidine (e.g. 2,5-bis(hydroxymethyl)-3,4-dihydroxypyrrolidine) and indolizine (e.g. 
castanospermine and swainsonine) derivatives (Figure 1.14) have been observed to inhibit 
glycosidases [27]. The aldonolactone derivatives are thought to act by mimicking the half 
chair conformation believed to be the intermediate in the mechanism of retaining 
glycosidases. The glycosylamines and aza sugars mimic the partial positive charge of the 
putative transition state of the enzyme.
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,0H ,0H
HOHO
HOHO
OH
D-gluconolactone D-glucosylamine
OH HO OH
NHHO
HO HOH2C'OH
l-deoxynojirimycin 2,5-bis(hydroxymethyl)-
3,4-dihydroxypyrrolidme
HO,
HOHO HOOH
castanospermine swamsomne
Figure 1.14: Known Glycosidase Inhnfeitors
A new class of glycosidase inhibitors are the amidines which are thought mimic the 
half chair conformation and the charge of the transition state intermediate as can be seen in 
Figure 1.15 [27].
A©OH OH
HO"HO
a) transition state in the 
hydrolysis of a P-mannoside
b) probable binding mode 
of a protonated amidine
Figure 1.15: Proposed Mode of Binding of a Protonated Amidine to a Mannosidase
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1.4.3 Glycosyl Transferases
An alternative strategy for interrupting the biosynthesis of complex glycoconjugates 
in mammalian systems is to inhibit the enzymes involved in the formation of glycosidic 
linkages. This class of enzymes is known as glycosyltransferases. The reaction catalyzed by 
these enzymes is the transfer of a monosaccharide unit from a nucleotide donor to the 
hydroxyl group of an acceptor sugar (Fignre 1.16).
Base HO OR1 or 2
Glycosyl Donor Glycosyl AcceptorHO OH
Glycosyl
Transferase
OR
Glycosylated Product
Figure 1.16: Glycosyl Transferase-Catalyzed Glycoside Synthesis
Glycosyltransferases are highly specific both in terms of the acceptor substrates 
used and in maintaining the stereo- and regio- control of the reaction. There are two distinct 
types of glycosyl transferase classified according to the stereochemical outcome of the 
reaction. The overall stereochemistry at the anomeric centre of the donor sugar is conserved 
during the reaction catalyzed by retaining enzymes. The second class of glycosyl 
transferase are inverting enzymes which effect an overall inversion of stereochemistry at 
the anomeric position of the donor. In order to account for all the different linlcages and 
configurations of oligosaccharides found in mammalian systems there would need to be 
over one hundred different glycosyltransferases.
The transglycosidases are also capable of forming glycosidic linlcages. Similar to 
the glycosidases described in Section 1.4.2 these enzymes are responsible for the cleavage 
of glycosidic bonds between sugar residues, but like the glycosyltransferases, rather than 
transferring the sugar unit to a water nucleophile, a new glycosidic linlcage is formed. For
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example, the trypanosome trans-sialiàaLse is capable of transferring a sialic acid residue 
from a pre-formed glycoconjugate to an oligosaccharide [29].
L4.3.1 Meckanism o f Gfycosyl Transfer
Understanding the exact mechanism for a glycosyl transferase is a non-trivial task 
due in part to the lack of crystal structures for any of the enzymes of this class. In an 
attempt to investigate the mechanism of glycosyl transfer Hindsgaul and co-workers [30] 
synthesized non-natural acceptor substrates for a variety of enzymes which had the 
hydi'oxyl group to be glycosylated replaced by a proton. The rationale behind this was that 
the transferase might still bind the deoxy substrate but that subsequent glycosylation would 
not then occur. The results of the study showed that for some glycosyl transferases the 
deoxy compounds were inhibitors of the enzyme (for example, p-l,6-GlcNAcT V). More 
interestingly however was the observation that for certain transferases (for example, p-1,4- 
GalT, a-l,3-FucT), no binding to the enzyme was observed when the deoxy compounds 
were used in the assay. This suggests that for some transferases there is a critical hydrogen 
bond between the enzyme active site and the hydroxyl group to be glycosylated on the 
acceptor molecule (Figure 1,17). The work canied out previously with glycosidases 
suggested that the active site of the enzyme may contain a general base such as the 
carboxylate side chain of glutamic or aspartic acid [30].
Base
Base
HO OH
HO OH OR--H— O ,BHOR
Figure 1.17: Critical Hydrogen Bond Interaction 
-the key hydrogen bond may play a role...
21
If this model is correct potential acceptor analogue inhibitors could be designed which 
would have a positively charged moiety at the position to be glycosylated. A charge-charge 
interaction would ensue preventing glycosyl transfer from occurring. Indeed, much work 
has been carried out into design and synthesis of amino acceptor analogues as inhibitors of 
glycosyltransferases similar to the work carried out previously with glycosidases. The 
enzyme iV-acetyllactosamine a - l,3 ’-galactosyltransferase (a-l,3-GalT) for example is 
strongly inhibited by the 3’-amino acceptor analogue (Fignare 1.18) [31]. Another example 
is inhibition of the transferases a-l,3-GalT and a-l,3-GalNAcT, involved in the 
biosynthesis of the blood group antigens A and B, by their respective 3-amino acceptor 
analogues [32].
0 H / ° " NHAc
OH (
0 — (CHalsCOOMer ^ o
Site of action of a-1,3-GalT '"ohi^ M=190|iiM
NHAc
HO—T-
r ^ o
OH (
K~lQ4\iM OH
Figrare 1.18: A Potent Inhibitor of a-ljS-GalT
However, there are enzymes that are not inhibited by their amino acceptor analogue. For 
example the amino acceptor analogue for bovine P-1,4-galactosyltransferase was a poor 
inhibitor for the enzyme and was in fact an apparent substrate (Figure 1.19) [33].
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,0H
HO
OBnHO
AcNH
Site of action of p-1,4-GalT
OBnHO
AcNH
Figure 1.19: Sabstrates for Bovine p i,4-Galactosyitransferase
1.4.4 Fncosyitransferase
Fucose residues are a common feature of cell surface carbohydrates. The enzymes 
responsible for catalyzing foimation of fucosides are loiown as fucosyltransferases. There 
are seven distinct fucosyltransferases that are involved in forming different linlcages with 
different acceptors. The most common fucose linkages found are a -1,2-, a - 1,3- and a - 1,4-, 
Each enzyme class differs in its tissue distribution, substrate specificity, cation sensitivity 
and its control of regiochemistry and anomeric configuration. However all 
fucosyltransferases are involved in catalyzing transfer of a fucose residue from guanosine 
diphosphate (GDP-fucose) to an acceptor molecule.
i. 4.4,1 a-1 f2-Fucosyltmusferase
a-1,2-Fucosyltransferase (a-l,2-FucT) catalyzes the transfer of fucose from GDP- 
Fuc to the 2-OH of an acceptor substrate. An example is GDP-Fuc Gal-P-R a-l,2-FucT 
which is one of the enzymes involved in the biosynthesis of the blood group O antigen. The 
acceptor is the terminal galactose of a glycoprotein. The mechanism of transfer is not fully 
understood but it is thought that the inversion of anomeric configuration results from a 
direct S^2 type displacement of GDP by the acceptor hydroxyl gi'oup (Figure 1.20) [34].
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,0H
,0H HO OR
HO OR
iuanosine
'^ o v '^ o v  ■^o—1OH-q  "O iuanosine HO OH
HO OH
,0H
HO OR
Guanosine
OH
HO OH
FIgere 1.20; Postulated Mechanism for a-l,2-FmcT
L 4,4.2 a-1,3-Fucosyltmnsferase
Many carbohydrates on the surfaces of cells contain fucose residues in a-1,3- 
linlcages. The formation of these linkages is catalyzed by a -1,3-fucosyltransferase enzymes 
which have been detected in a wide range of tissue types in mammalian systems [35] and 
have also been detected in plants, insects, bacteria (e.g. Helicobacter pylori) and snails (for 
review see [36]). The reaction catalyzed by a-l,3-FucT is the transfer of fucose from GDP- 
Fucose to the 3-OH of an acceptor sugar commonly 2-acetamido-2-deoxy-D-glucose 
(GlcNAc).
Five distinct types of human a-l,3-FucT have been cloned, III, IV, V, VI and VII, 
all of which have been shown to have different acceptor sugar specificities ( 
Table 1-2). One of these enzymes is unique as it can transfer a fucose residue to both type I 
chains (Gal-p-1,3-GlcNAc-p-OR) and the type II chains (Gal-p-l,4-GlcNAc-p-0R). It is 
therefore capable of catalyzing the formation of two different glycosidic linkages (a-1,3- or 
a -1,4-), This enzyme is known as the Lewis a-l,3/4-FucT III. It has the broadest acceptor
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specificity range found among the human a-l,3-FucT’s and can accept both sialylated and 
non sialylated substrates [37], [38].
Enzyme Tissue DistributioM Substrates Products
1 a-l,3-FucT m human mille, gall 
bladder, kidney, 
colon
type I, type II,
sialyl type 1 + II
fixcosyl type I + II, 
lactose, 2-fucosyl- 
lactose
Le% sLe®, Le’’, 
Le\ sLe\ Le^
a-l,3-FucT rv brain, myleoid cells type II, sialyl type 
II
Le’', sLe’'
a -1,3-FucT V plasma, human milk, 
liver
type II, sialyl type 
II
Le’', sLe’', sLe^
a-l,3-FucT VI plasma, kidney, 
liver, colon
type II, sialyl type 
II, fucosyl type II
Le", sLe", sLe"
1 a-l,3-FucT VII leulcocytes sialyl type II sLe"
Table 1-2; Biochemical Properties of Human a-l,3-Fucosyltramsjkrases.
a-l,3-FucT IV - VII differ from III in that they cannot form a-l,4-linlcages. a-1,3- 
FucT IV has been found to have the narrowest acceptor specificity range, having little or no 
activity with sialylated acceptors. It appears therefore to be ineffective in synthesizing sialyl 
Lewis X [3]. It is thought a-l,3-FucT V is responsible for the terminal step in the 
biosynthesis of Lewis x and sialyl Lewis x [39]. a-l,3-FucT V and VI have similar 
substrate specificities however a-l,3-FucT VI is more restricted and shows poor activity 
with Fuc-a-1,2-Gal-p-l,4-GlcNAc-R [3]. The final enzyme in this group, a-l,3-FucT VII, 
was the last to be cloned and is reported to give rise to cell surface sLe’^ expression but not 
Le’' [40]. Recent evidence suggests that a-l,3-FucT VII participates in the biosynthesis of 
sLe" in leukocytes [41].
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L4,4J Meckmmsm o f a-l,3-FucT V
Wong and co-workers [42], [39], [43] have carried out extensive studies on the 
mechanism of human a-l,3-FucT V. Transfer of fiicose has been demonstrated to occur 
with inversion of anomeric configuration. The mechanism which was put forward by Palcic 
and co-workers [44] for a-l,2-FucT postulated an ion pair intermediate (Figure 1.20). It is 
possible that a-l,3-FucT*s work in a similar manner, the hydroxyl of the acceptor sugar 
displacing GDP from the donor. The active site base could assist in this by helping to 
deprotonate the hydroxyl of the acceptor. This mechanism is similar to that proposed for 
glycosidases [25]. Support for a process with this type of transition state comes from the 
obseiwation that aza-sugars which mimic the char ge of the transition state are inhibitors of 
a-l,3-FucT V and that in the presence of GDP they apparently become more potent 
inhibitors suggesting that a mimic of the transition state is forming in the assay [45]. 
Inhibition studies also demonstrated that GDP was a non-competitive inhibitor of a-1,3- 
FucT V and that at high concentrations of GDP-fucose potent substrate inhibition was 
observed suggesting that glycosyl transfer in a-l,3-FucT V involves a sequential 
mechanism with GDP-fucose binding first and the product GDP releasing last [42]. Wong 
and co-workers [39] also carried out pH-rate profile studies which supported the hypothesis 
for a catalytic active site base. The pKa of this base was found to be 4.1, comparable to that 
of a carboxylic acid. Solvent kinetic isotope studies have demonstrated that there is one 
transferable proton involved in the catalytic transition state. More recently inhibition 
studies have been carried out using an unnatmal 2-fluoro-2-deoxy GDP-fucose derivative. 
The strategy for this comes from the work carried out previously with glycosidases [46]. 
This donor substrate was found to be a competitive inhibitor of the enzyme (Ki = 4.2 pM). 
This result differs from that obtained for glycosidases, the 2-fluoro derivatives were found 
to be slow substrates for retaining glycosidases. These observations led Wong and co­
workers [43] to conclude that glycosidic cleavage occurs prior to nucleophilic attack for the 
enzyme a-l,3-FucT V.
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L J  Z lra w ^ r
1.5.1 The Role of MetuI Ions m  Euzymatk Catalysis
It is well established that metal ions play an important and diverse role in biological 
processes. For example metal ions are involved in such processes as oxidation and oxygen 
transport. An example is the zinc containing enzyme carbonic anhydrase which is 
responsible for the hydration of caibon dioxide to yield bicarbonate. It is thought that the 
nucleophile in the reaction is a zinc bound hydroxide moiety which attacks carbon dioxide 
forming a zinc bound bicarbonate ion (Fsgnire 1.21) [47].
' \ ©
Hisii9 HiS94^t ^  
Hisge
CO2
Fignare 1.21; Proposed Mechanism of Carbonic Anhydrase
In this manner the zinc is acting by effecting a reduction of pKa of the bound water 
molecule, thereby increasing the nucleophilicity of the oxygen atom. A related mechanism 
has been proposed for inositol monophosphatase which utilizes a Mg^  ^ bound water 
molecule as the nucleophile in the hydrolysis of inositol monophosphate. An added 
requirement for catalysis with this enzyme is the carboxylate side chain of glutamic acid 
[48], [49].
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1.5.2 Role off Metal ïosis :m Glycosyl Transferases
It has been established that for some glycosyl transferases, for example, P-l,4-GalT, 
divalent metal ions play an important role in the mechanism. In many cases maximum in 
vitro activity is observed in the presence of divalent manganese cations [50]. During studies 
with p-l,4-GalT isolated from bovine milk, Powell and co-workers [51] identified that there 
were two distinct metal ion activation sites. Site I is occupied by a tightly bound Mn^  ^ ion 
and can be satisfied with 10-20 pM concentrations, an attainable in vivo concentration 
range [50]. The Mn^  ^ions occupying Site II however are bound less tightly and saturation 
requires a concentration of 10-20 mM, a far greater concentiation than is likely to he 
attained in vivo (in vivo Mn^  ^ concentration is close to or less than 10'^  M almost 
everywhere inside or outside cells) [52], [53]. Studies have shown that for many glycosyl 
transferases the Mn^  ^ ions can be replaced by other metal ions having an octahedral 
geometry such as Mg^ ,^ Ca^  ^ and Co^ .^ This substitution, however usually has an adverse 
effect on the rate of glycosyl transfer. This reduction in rate can be explained if it is 
assumed that these alternative metal ions occupy Site II and that there is incomplete 
occupancy of Site I by endogenous ions (Mn^^). The gieater rate observed when Mn^  ^ ions 
are used could be due to their ability to satisfy both sites on the protein.
Base
Base..o-
HO OH
HO OH ORH— O BHOR
Figure 1.22: Proposed Role off the ‘‘Catalytic’ Mb ton m Glycosyl Transferases.
The Mn^  ^ion at Site I is thought to have a structural role due to the tight binding observed, 
whereas the role of the metal ion at Site II is assumed to be catalytic. It is believed that this 
‘catalytic’ Mn^  ^ ion coordinates the pyi'ophosphate group of the NDP-sugar substrate
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(Figure 1.22). For p-l,4-GalT Idnetic studies have suggested that an enzyme-Mn^^-UDP- 
galactose complex may exist [51].
1.5.2.1 OrlfS’^’Fucosyltmmferase.
Wong and co-workers [39] have shown that there is a manganese ion dependence 
for the enzyme a-l,3-FucT V. Kinetic studies have revealed that in order to attain half 
maximal activity it is necessary to have 6.1mM Mn^  ^ ion concentration (GDP-Fuc
0.050mM, LacNAc 20mM). Similar to the studies described above, the endogenous metal 
ions were dialyzed from the protein and other metal ions were used in kinetic experiments. 
It was found that Mn^  ^ions could be replaced with Ca^ ,^ Co^  ^or Mg^ ,^ giving relative rates 
with respect to Mn^  ^ of 63%, 56% and 53% respectively. From these studies it was 
concluded that for a-l,3-FucT V there is a preference for divalent metal ions that can adopt 
an octahedral geometry. The model postulated for this Mn^  ^ ion dependence, was 
coordination of the metal ion to the pyrophosphate group of the donor substrate based on 
the fact that for both p-l,4-GalT and a-l,3-FucT the following order of inhibition was 
observed: NDP > NMP > N.
1.5.2.2 An Alternative Mole fo r in Glycosyl Transferase Reactions?
Although it is known that in certain glycosyl transferases the rate of transfer can be 
enhanced by the presence of divalent metal ions (Mn^^), it is not clear what the mechanism 
of this cationic activation is. The current thought is that the ‘catalytic’ Mn^  ^coordinates the 
pyrophosphate group of the donor sugar (Figure 1.22). However, there is little direct 
experimental evidence to substantiate this theory. If the Mn^  ^ ions involved in the 
mechanism of glycosyl transfer are associated with the acceptor substrate a mechanism 
similar to that for carbonic anhydrase or inositol monophosphatase could he proposed for 
glycosyl transferase enzymes. This would involve coordination of the Mn^  ^ to the active 
hydroxyl gi'oup of the acceptor (Figure 1,23). The overall effect of this coordination would 
be lowering of the pKa of the hydroxyl group and thus increasing the nucleophilicity of the 
oxygen to attack the donor substrate. It has been shown from the work of Hindsgaul and co­
workers [30] that there may be an active site base involved during glycosyl transfer. This
29
may also coordinate the ions helping to orientate the metal ion for coordination to the 
acceptor substrate (Figure 1.23).
OR
Figiare 1.23; Proposed Mole of m Glycosyl Transfer.
Evidence to suggest that this type of mechanism could occur for glycosyltransferases comes 
from the proposed mechanism for oligosaccharyltransferase.
1,5,23 OUg&smcchmyl Tmmferase
One of the enzymes involved in the biosynthesis of /V-linlced glycoproteins is 
oligosaccharyltransferase. This enzyme facilitates the transfer of oligosaccharides onto the 
asparagine side chain of a protein (Figure 1.24, where X=0).
OH
HO OH
AcHN dol
NHMeBz— N
= 0  or S
Figure 1.24: Mechanism of Oligosaccharyl Transferase
It is Imown that this enzyme has a dependence on divalent metal cations although 
the role of these cations is unclear. It was found that although Mn^  ^could be replaced by 
other divalent metal cations (Ca^ ,^ Fe^  ^ and Mg^ )^ this resulted in a 50% loss of activity. 
Imperiali and co-workers [54] argued that this preference for Mn^  ^ ions suggests that the 
metal co-factor is not coordinated to the pyrophosphate group of the donor but is in close 
proximity to the acceptor substrate (Figure 1.24). If the metal ion coordinated the
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pyrophosphate gi’oup it would be expected that replacement of with would result 
in an increase in activity due to the affinity of for phosphate moieties. In an attempt to 
establish the role of the metal co-factor Imperiali and co-workers synthesized an unnatural 
substrate for the enzyme (Figure 1.24, where X=S). This substrate has the carbonyl gi'oup 
on the side chmn of asparagine substituted by a thiocarbonyl. The rationale for this study 
was that the sulfur containing compound would have a different affinity towards the Mn^ "^  
cation. The thiol compound was found to have a similar (~ 380 frM) to that of the 
natural substrate but the was an order of magnitude lower. When alternative metal co­
factors were used in the Idnetic studies, it was found that the thiophilicity of the metal 
directly correlated with the observed rates of turnover, Fe^  ^ions giving the highest overall 
rate of transfer. It was also observed that when metals such as Mg^  ^ (oxophilic) were used 
as co-factors poor rates of turnover resulted. Thus it was concluded that the metal co-factor 
was associated with the acceptor substrate and not the pyrophosphate group of the donor 
substrate.
1.5,3 Other Comtatalng Enzymes
L 5,3,1 Fmctose-’lf 6-Bispkosphatase
Fructose-1,6-bisphosphatase (FBFase) is involved in the gluconeogenic pathway 
and catalyzes the conversion of D-fmctose-1,6-bisphosphate to D-fmctose-6-phosphate 
(Figure 1.25).
o—P—0 OH——o —p—o FBPaseOH OH OHHO;
OH OH
OH OH
Figure 1.25: Reaction Catalyzed by FBPase.
The presence of divalent metal ions is essential for this reaction to occur. Divalent 
magnesium, manganese, zinc or cobalt can all be used effectively during catalysis. It is 
believed that there are between one and three metal ion sites. Only one Mn^  ^cation binds in 
the absence of substrate however two ions bind in the presence of substrate [49]. A crystal
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2+Structure of the enzyme bound to an inhibitor (2-OH replaced by H) shows the two Mh 
ions to be separated by 3.7 Â. The ions are bridged by two carboxylate side chains of 
amino acids Glu-98 and Asp-118 (Figmre 1.26).
'oh \HC
Figure 1.26: Putative Mechanism of FBPase.
The two metal ions (Mj and Mj) are thought to orientate the substrate for attack by the 
water nucleophile and to stabilize the transition state. The pKa of the water molecule is 
reduced by coordination to Mj facilitating in the general base deprotonation of the water 
molecule by Glu-97. Further support for this mechanism comes from the observation that 
substrates lacldng 2-OH are resistant to enzymatic cleavage.
i .5.3.2 Arginase
One of the enzymes involved in the disposal of nitrogenous waste from mammalian 
systems is arginase. This enzyme is responsible for the hydrolysis of arginine in the final 
step of the urea pathway (Figure 1.27).
NH
Arginase
Figure 1.27: Hydrolysis of Arginine
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Christianson and co-workers [55] recently published the crystal structure of arginase 
isolated jfrora liver tissue. It was found that this enzyme contains a binuclear manganese 
cluster at the active site of the enzyme. Each subunit of the enzyme contains two spin 
coupled Mn^  ^ions that are an absolute requirement for activity. The separation of the metal 
centers was found to be 3.4-3.6Â however this distance narrows in the presence of 
inhibitors. This suggests that substrates are bound directly to the Mn^  ^ site. This Mn^  ^ - 
Mn^  ^ distance is also consistent with the presence of one or more bridging carboxylate 
residues. Kinetics studies have revealed that there is a functional group with a pKa of 7.9- 
8.0 that is responsible for controlling the hydrolysis rate at the guanidinium carbon of the 
L-arginine substrate. This is consistent with an active site base which it is presumed 
deprotonates water forming the hydroxide nucleophile for the reaction (Figure 1.28). It is 
therefore assumed that arginase effects hydrolysis by lowering the pKa of a bound water 
molecule by forming a binuclear manganese cluster, thus increasing the nucleophilicity of 
the water molecule [56].
Glu
Asp
Figure 1.28: Proposed Mechanism for Arginase
33
L é Observations and Objectives
It is evident from the examples shown that there are many similarities between 
enzymes containing divalent metal cation sites. For example many of the enzymes 
described have a requirement for an active site general base, commonly the carboxylate side 
chain of aspartic or glutamic acids. In some cases it has been shown that the metal ion plays 
an important role in the mechanism of the reaction and is not present purely in a structural 
capacity. Carbonic anhydrase for example utilizes the divalent metal ion (Zn^ )^ to effect an 
overall loweiing of the pKa of a bound water molecule. It has been established that divalent 
metal ions are important in glycosyltransferase reactions, in some cases it is an absolute 
requirement, however it is not clear what role these metal co-factors play. An additional 
similarity between glycosyltransferases and other Mn^  ^containing enzymes is the presence 
of an active site base which is thought to deprotonate the bound hydroxyl group. Perhaps it 
is possible for the Mn^  ^ions to coordinate the hydroxyl group of the acceptor substrate in a 
similar manner to that for arginase and FBPase. This would have an overall effect of 
increasing the nucleophilicty of the oxygen of the acceptor substrate towards attack on the 
nucleoside diphosphate donor.
Unpublished work by Palcic and co-workers (personal communication) has shown 
that perhaps the simple general base mechanism proposed by Hindsgaul and co-workers 
(Figure 1.17) does not tell the whole story for the mechanism of fucosyl transfer. A panel 
of compounds were synthesized whereby hydroxyl groups around the disaccharide acceptor 
substrate were systematically substituted with sulfate moieties [57]. The results obtained 
are shown in Figure 1.29. An unusual result was obtained for the 3-O-sulfate derivative. It 
was expected that this analogue would be a non-substrate due to the presence of a negative 
charge at the site of glycosylation. This would interfere with the general base activation of 
the acceptor molecule. However it was found that this unnatural analogue was in fact a 
substrate for the enzyme with kinetic parameters similar to those for the unsubstituted 
compound. Although this result does not prove or disprove the previously proposed 
mechanism for glycosyltransferases, it does suggest that perhaps the mechanism is more 
complex than previously supposed. The mechanism postulated in this thesis however can 
explain the results obtained for the 3-O-sulfate derivative.
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Figure 1.29: Kinetic Data for Snifated Acceptor Substrates with 
a-l^-Fucosyitransferase (milk)
The objective of this thesis was therefore to further investigate what role divalent 
metal ions have in the mechanism of a-1,3-fucosyltransferase. The strategy for achieving 
this objective was to synthesize unnatural acceptor analogues containing anionic 
functionalities at the site of glycosylation. These anionic groups should have a different 
affinity for the metal ion and thus by measuring the Idnetic parameters of these substrates 
with the enzyme it may be possible to determine whether the Mn^  ^cation is associated with 
the acceptor substrates as postulated in this thesis.
The following chapter will discuss in more depth the strategy of work for this thesis. 
Chapter 3 will discuss the chemical synthesis of the target molecules undertaken during this 
project. Chapter 4 will contain the experimental details for the chemical synthesis. The 
results of the biological testing of these molecules will be presented in Chapter 5. Chapter 6 
will diaw some conclusions from the work carried out.
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To design effective substrates for an enzyme it is necessary to consider the 
minimum substiate tolerated by the enzyme, the acceptor specificity and the sites 
important for enzyme recognition. It is known that a-l,3-FucT’s are involved in the 
terminal step in the synthesis of sLe’^ terminating units of glycoconjugates and it has 
been shown that for most a-l,3-FucT’s the minimum substiate tolerated by the enzyme 
is a disaccharide unit based on the Gal-p-1,4-GlcNAc core unit. The exception to this is 
a-l,3-FucT v n  for which it is reported the trisaccharide NeuAc-a-2,3-Gal-p-l,4- 
GlcNAc is the minimum substrate tolerated [1]. Another exception is a-l,3-FucT III 
which accepts Gal-P-1,4-GlcNAc and Gal-p-1,3-GlcNAc disaccharides. Work carried 
out by Palcic and co-workers [2] has determined the sites important for enzyme 
recognition of an acceptor substrate for the Lewis a-l,3/4-FucT (human milk). These 
sites are shown in Figure 2.1.
NH-CO-CH2CH3....active 
NH2 poor
,0HOH AcNH
OR
OH
OHSialic acid
Fucose
Figure 2.1; The Sites Important for Recognition with Lewis a-l^/4-FncT  
The sites circled are important for recogntion by the enzyme and modifications are not tolerated. 
The sites in boxes can be modified to some extent without inactivating the enzyme.
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2.2 Target Molecules
The target molecules chosen to investigate the role of the divalent metal cation 
in the mechanism of fucosyltransferase catalyzed reactions are shown in Figure 2,2.
NHAc
NHAc
O-octyl
0 -octyl
X = OH 
X = OSO3 
X = OP03 
X = OH 
X = OH 
X = OSO3
2-
Y = OH
Y = OH
Y = OH
Y = 0S(%"
Y = OPO3"
Y = OSC%“2-X = 0PQ3 Y = OP%2-
Flgure 2.2: Target Molecules
These target molecules are disacchaiides containing a D-galactose p-linlced to either the 
3-OH or 4-OH of an iV-acetylglucosamine residue, thus forming type I and type II 
chains. All molecules contain a p-linkage to an octyl function, enabling purification of 
these molecules from biological mixtures by reverse phase chromatography using C,g 
SepPalc cartridges [3]. In the natural substrate the site occupied by this octyl chain 
would be a glycoprotein or glycolipid. It has been shown however that the biological 
activity of compounds containing a hydrophobic tail is not impaired and in fact for 
bovine p-l,4-GalT binding to the enyme has been demonstrated to be in the same range 
as for the natural glycans ~ 150-200 pM) [4],
To investigate the role of the divalent metal cation in fucosyltransferase 
reactions it was decided to prepare sulfated and phosphorylated derivatives of octyl 
lacNAc. These anionic functionalities should have a different affinity for the metal ion 
than the corresponding hydi'oxyl group. From the observations made by Palcic and co- 
workers (unpublished) (Sectlom 1.6), it was concluded that the sulfate group at the site 
of glycosylation was being fucosylated thus forming an unstable sulfate diester linlcage. 
The rationale, then for preparing phosphorylated derivatives was to try and identify the 
product of the reaction. Glycosyl phosphate diester linlcages are Icnown in nature [5] and
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should therefore be stable enough to allow isolation and characterisation of any 
phosphate diester product formed during the reaction.
It has been reported that the enzyme a-l,3-FucT VII requires a sialic acid at the 
3'-OH for activity [1], therefore it was also decided to prepare the a-2,3-linl(ed sialic 
acid derivatives of the compounds shown in Figure 2.2 . Work cunently ongoing in our 
laboratories uses a rra«5-sialidase enzyme from Trypanosoma cruzi to synthesize a-2,3- 
sialic acid glycosides and so these sialylated compounds were to be prepared using an 
enzymatic method (Chapter 5).
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It is now well established that carbohydrates linked to proteins or lipids are involved 
in many important biological processes (Chapter 1). This increased appreciation of the role 
of these molecules in the biological sciences has resulted in a revival in carbohydrate 
chemistry. Synthetic analogues of biologically active oligosaccharides may provide 
essential information about stmcture-function relationships and may provide information 
about binding and interaction with other biopolymers. However synthesis of 
oligosaccharides is a non-trivial task due in part to the multi-functionality of such 
molecules. All monosaccharides involved in the synthesis of biologically active 
oligosaccharides contain at least three hydroxyl gioups and the anomeric carbon can have 
two different configurations (a or P). Each coupling reaction has to be performed regio- 
and stereo-selectively and therefore the complexity of synthesis grows with the length of 
oligosaccharide chain.
3.LÎ Orthogonal Protection Strategies :m Carbohydrate Chemistry
The presence of three or more hydroxyl groups in each monosaccharide residue 
forces the need for orthogonal protection strategies in oligosaccharide synthesis. During a 
coupling reaction it is often desirable to have only one fi*ee hydroxyl group present. In order 
to achieve this level of protection, many protection and deprotection steps might need to be 
employed. Carefiil choice of protecting group is therefore required when designing 
syntheses of oligosaccharides. For further information see [1].
3.1.2 GlycosylatioE Methods
Only a brief outline of some of the strategies employed during glycoside synthesis 
will be presented here. For review information see [2].
3.L2.1 Neighboming Group Participation
Coupling reactions in carbohydrate chemistry are usually achieved by reaction of 
the anomeric carbon of a fully protected sugar residue (glycosyl donor) with a free hydroxyl 
group of suitably protected sugar (glycosyl acceptor). Controlling the stereochemical 
outcome of the reaction is a difficult task and often mixtures of anomers are formed which
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have to be separated by chromatography. To a certain extent the stereochemical outcome of 
a glycosylation reaction can be controlled by careful choice of the protecting group at 
position 2 of the glycosyl donor and the anomeric leaving group. The solvent and promoter 
used in the reaction are also important. For example, if a halide glycosyl donor is chosen 
which has an ester functionality at position 2 , then a p-glycoside would be expected as the 
glycosylation product due to neighbouring group participation (Scheme 3-1). The incoming 
alcohol attacks in an S^2 reaction from the top face of the molecule resulting in formation 
of the p-anomer exclusively.
,0P ,0P
PO PCPO PO
O promoter
,0P ,0P
ROMPO POORPO PO
©O
Scheme 3-1: Use off ParMdpsting Groups m Glycosylation Reactions
However if no participating group is present at position 2 the likely configuration of a 
glycosylation reaction would be a  due to the anomeric effect [1]. This can be altered if a 
suitable solvent is used in the reaction, for example, acetonitrile which is able to participate 
in the reaction (Scheme 3-2).
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^  ROMPO POPO
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promoter
.OP
PO ORPO
OBn
Scheme 3-2: Acetonitrile as a Participating Solvent in Glycosylation
3,1,2.2 Leaving Groups and Promoters
Halides, usually chlorides or bromides, have tiaditionally been used as leaving 
groups in glycoside synthesis. With a careful choice of promoters, reaction conditions and 
type of protecting groups a- and p-anomers can be prepared with high selectivity. 
However, glycosyl halide donors are rather unstable and as such have proved unsuitable in 
convergent synthesis where blocks of oligosaccharides are coupled together. More recently 
trichloroacetimidates (Scheme 3-3) [3] and thioglycosides [2] (Scheme 3-4) have come 
into common use as glycosyl donors.
NH
CCI3
Scheme 3-3: Glycosylation Reaction using Tricliloroacetimidate Donor
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E-X
SR
-ESR
HOR2
R^ O"— ^ R^ O
Scheme 3-4: Activatiou of Thioglycosides with a ThiophlMc Reagent (E-X) [2]
The choice of promoter for a glycosylation reaction is dependent on the choice of 
glycosyl donor and must also talce into consideration the reactivity of the glycosyl acceptor. 
Table 3-1 shows some glycosyl donors and their respective promoters.
Glycosyl Donor Promoter
Br Br, HgCNj, HgBrg, AgOTf
Cl HgCN2,HgBr2,AgOTf
F SnCl^-AgClO,, AgOTf-SnClj
SR TfDH-NTS
OAc BF3, SnCl4,TMS0 Tf
(CH2)3CH=CH2 TfOH-NIS, AgOTf-NIS, 
TESOTf-NIS
HN=CCCl3 BFa-Et^O, TfOH, TMS-OTf
SO.Ph T^O
SON TMSOTf
SCS.(OEt) Cu(0 Tf)2
Table 3-1: Commonly Used Glycosyl Donors and their Promoters
An alternative method for synthesizing oligosaccharides is to use an enzymatic 
method or a combination of chemical and enzymatic synthesis. This topic will be covered 
in Chapter 4.
M9M<y- a»<f accAwM eg
The target molecules shown in Chapter 2 were prepared from suitably protected N- 
acetyllactosamine derivatives. The monosaccharide starting materials used were N- 
acetylglucosamine and D-galactose.
3.2.1 Synthesis of the Glycosyl Domor;- 2,3,4,6-Tetra-O-acetyl-a-D-galactopyranosyl
Bromide (3).
Penta-0-acetyl-a/p-D“galactose (2) was prepared by reaction of D-galactose (1) 
with acetic anhydride in pyridine (Scheme 3-5). The crude product of the reaction was 
converted to the glycosyl bromide (3) using hydrogen bromide in acetic acid.
pH P A c P A cOH AcO AcOHBr, AcOH 
O CH2CI2
AcOHO
OH OH AcO OAc AcO
43% overall
Scheme 3-5: The Synthesis off Acetoforomogalactose (3)
3.2.2 Synthesis off Glycosyl Acceptor for Chemical Conplmg; Octyl 2-Acetamido-3,6- 
di-O-benzyl-2-deoxy-p-D-gincopyranoside (10)
The overall synthetic scheme for synthesis of octyl 2-acetamido-3,6-di-0-benzyl-2- 
deoxy-p-D-glucopyranoside (10) is shown in Scheme 3-6.
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,0H PAC CH3(CH2)70H 
HgCNj, HgBrz 
toluene
,OAc
AcHN^OH
HO AcO-^
AcOHO O-octylAcO 75%AcHN AcHN
NaOMe, MeOH
pH
PhCH(OMe)j, CH3CN 
p-TsOH HO0 -octyl ^HO O-octylHO78%AcHN AcHN
BnBr, NaH 
DMF , 74%
OBn
o-°otyi 66% O-octyl
AcHN AcHN
(10)
Scheme 3-6; The Synthesis of Octyl 2-acetamido-3,6-di-0-benzyl-2-deoxy-p-D-
Glncopyranoslde (10)
2-Acetamido-3,4,6-tri-0-acetyl-2-deoxy-a-D-glucopyranosyl chloride (5) was 
prepared by reaction of acetyl chloride with iV^-acetylglucosamine as reported by Horton [4]. 
However, the reaction was found to be slower than reported and typically gave lower yields 
(approximately 40%). Pentaacetylglucosamine is formed as an intermediate in the reaction 
releasing hydrogen chloride gas which attacks the anomeric carbon displacing acetic acid to 
form the iV-acetylglucosaminyl chloride (S) (Scheme 3-7).
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AgoHO AcO AcOHO AcO
AcHN OH AcHN /O A c AcHN
,OAc
AcO
AcO
AcHN
Scheme 3-7; The Synthesis of 2-acetanldo-3,4,6-trl-0-acetyl-2-deoxy-p-D-
glucopyranosyl Chloride (S)
The low yields and slow rate of the reaction were thought to be due to loss of the hydrogen 
chloride gas produced in situ. Several different procedures were attempted to try and 
generate more hydrogen chloride gas during the reaction and thus force the reaction to 
completion. Addition of acetyl chloride presaturated with hydrogen chloride gas to a flask 
containing A -^acetyl glucosamine was found to be the best method of synthesizing the 
glycosyl chloride. The yields and reaction time were much improved compared with the 
initial attempts described.
Using the glycosyl chloride obtained above octyl 2-acetamido-3,4,6-tii**0-acetyl-2- 
deoxy-p-D-glucopyranoside (6) was prepared by a standard Koenigs-Knorr coupling 
procedure using mercury cyanide and mercury bromide as promoters [5]. The 
stereochemistry at the anomeric position was confirmed to be p by n.m.r. spectroscopy; the 
a  anomer was not detected. The anomeric selectivity of this coupling reaction of 2- 
acetamido-3,4,6-tri-0-acetyl-2-deoxy-a-D-glucopyranosyl chloride (S) to octanol can be 
predicted by considering the mechanism of the reaction. The mercury salts are halophilic 
and serve as promoters in the reaction by abstracting the chlorine at position 1 of the 
glycosyl chloride (S) (Scheme 3-8). The intermediate carbonium ion formed is stabilized by 
participation of the acetamido group at position 2. This leaves only the p face of the sugar 
residue open to an attack by octanol.
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AcHN H -N
Me
,OAc
AoO-^AcO
AcHN
Scheme 3=8: The Mechanism off the Conpltfflg Reaction
A problem encountered during the synthesis of octyl 2-acetamido-3,4,6-tri-0-acetyl-
2-deoxy-p-D-glucopyranoside (6) was identifying the product by t.l.c.. The acetyl protected 
octyl 7V-acetyllactosamide had a similar Rf value to the glycosyl chloride starting material. 
To confirm this observation a small amount of (8-methoxycarbonyl)octyl 2-acetamido-2- 
deoxy-p-D-glucopyranoside [5] was acetylated and the Rf values of this and (S) were 
compared. This t.l.c. comparison confirmed that 2-acetamido-3,4,6-tri-0-acetyl-2-deoxy-a- 
D-glucopyranosyl chloride (S) and octyl 2-acetamido-3,4,6-tri-0-acetyl-2-deoxy-p-D- 
glucopyranoside (6) have similar Rf values.
Compound (6) was deprotected using sodium methoxide and methanol to produce 
octyl 2-acetamido-2-deoxy-p-D-glucopyranoside (7) in quantitative yield (Scheme 3-6). 
Octyl 2-acetamido-4,6-C>-benzylidene-2“deoxy-p-D-glucopyranoside (8) was prepaied by 
reaction of alcohol (7) with benzaldehyde dimethyl acetal and / 7-toluene sulfonic acid in 
acetonitrile. Alcohol (7) was insoluble in acetonitrile but dissolved on addition of 
benzaldhyde dimethyl acetal. A white precipitate of alcohol (8) instantaneously formed in 
the reaction vessel.
The 3-hydroxyl group of octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-P-D- 
glucopyranoside (8) was protected by reaction with benzyl bromide and sodium hydride in 
dimethylformamide to yield octyl 2-acetamido-3-0-benzyl-4,6-(7-benzylidene-2-deoxy-p- 
D-glucopyranoside (9) . It was necessary to add only small aliquots of sodium hydride at
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any one time and monitor the reaction carefully by t.l.c.. If the reaction is allowed to 
progress beyond formation of the monobenzyl derivative, the nitrogen of the acetamido 
group can become benzylated. This reaction was quenched by addition of water which 
resulted in compound (9) precipitating as a white solid [6].
Using a selective acetal ring opening procedure it is possible to cleave benzylidene 
acetal protecting gioups leaving the 6-position protected with a benzyl group while the 4- 
position is deprotected. The regioselectivity of such an acetal ring opening procedure can be 
explained by considering the mechanism proposed by Garegg and co-workers [7] as shown 
in Scheme 3-9. This mechanism shows two possible products from a reductive benzylidene 
acetal ring opening. Which alcohol (4- or 6-OH) is obtained depends on the nature of the 
electrophile, E. If E is, for example, a Lewis acid such as aluminium chloride, the reductive 
ring opening is likely to be directed towards path (a) due to the steric demand of the bulky 
electrophile. For the case where E is a proton, for example, in sodium cyanoborohydride 
reductions using HCl, the steric demand of the proton is less and so the direction of the 
equilibrium will depend on the relative basicities of the 0-4 and 0-6 and the reductive 
acetal ring opening is directed towards path (b).
X— H
GO
BO
Scheme 3-9: Mechanism for Reductive Ring Opening of Benzylidene Acetals [7]
Considering the mechanism for the regioselective benzylidene acetal ring opening 
reaction described above, the method required for the ring opening of compound (9) 
employs sodium cyanoborohydride and hydrogen chloride in tetrahydrofriran under
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rigorously anhydrous conditions [7]. Octyl 2-acetamido-3,6-di-0-benzyl-2-deoxy-p-D- 
glucopyranoside (10) was synthesized in only moderate yields (typically 60%) due to the 
competing formation of octyl 2-acetamido-3-0-benzyl-2-deoxy-p-D-glucopyranoside 
(10a), (Scheme 3-10).
PBn .OH
BnO O-octylO-octyl O-octyl
AcHN AcHN
(10)
AcHN
(10a)
.OH
BnO O-octylBnO
AcHN
(10b)
Scheme 3-10: The Acetal Ring Opening Reaction and the Side Products Formed.
A recent publication by DeNinno and co-workers [8] showed an alternative route for 
selective cleavage of benzylidene acetal rings to give the same regiocontrol described for 
the reaction involving sodium cyanoborohydride. The paper reports the procedure to require 
less rigorously anhydrous conditions than the above mentioned procedure using sodium 
cyanoborohydride, and the yields quoted were typically 80-90% with no formation of the 6-
alcohol (10b), or the 4,6-diol (10a) (Scheme 3-10). Following the work of DeNinno and\
co-workers, attempts were made to selectively cleave the benzylidene acetal of octyl 2- 
acetamido-3-(9-benzyl-4,6-0-benzylidene-2-deoxy-P-D-glucopyranoside (9) using triethyl 
silane and trifluoroacetic acid in methylene chloride. Initial attempts to selectively cleave 
the benzylidene acetal showed the major product to be the 4,6-diol (10a). A reason for the 
formation of the diol (10a) could be due to trace amounts of water being present in the 
reaction flask. Aqueous acids are commonly used to cleave benzylidene acetals. Later 
attempts using anhydrous conditions were more successful, however the reaction was not 
selective as the desired 4-alcohol (10), the 4,6-diol, (10a), and the 6-alcohol, (10b), were 
isolated and identified by n.m.r. spectroscopy.
A more successful method for selective cleavage of the benzylidene acetal of 
compound (9) was using lithium aluminium chloride and borane trimethylamine complex
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as reported by Vasella and co-workers [9]. According to Garegg and co-workers [7] in 1982 
this method should give the 6-hydi‘oxyl free leaving the benzyl ether at the 4-OH. However 
a later publication by the same author [10] reported that if tetrahydrofuran was used as a 
solvent rather than methylene chloride a reversal of regiochemical outcome occurred. This 
procedure was adopted and gave the desired product in reasonable to high yields with no 
observed formation of side products. However, disadvantages were the slow rate of reaction 
and the large quantities of the borane salt needed which had to be removed from the 
reaction mixture by column chromatography.
3.2.3 Synthesis of Sulfate and Phosphate Derivatives of Octyl GlcNAc
As a model study the sulfate and phosphate derivatives of octyl 2-acetamido-2- 
deoxy-p-D-glucopyranoside were prepared (Scheme 3-11). These may act as substrate or 
inhibitors for the enzyme bovine p-1,4-galactosyltransferase (Chapter 4).
AcHN
O-octyl
i. SO^.Me^N, py
ii. H2, Pd-C, MeOH, AcOH ------------------
75%
S — 0
AcHN
O-octyl
i. (BnO)2PN(iPr)2, CH2CI2, 
1-H tetrazole
ii. mCPBA
iii. H2, Pd-C, MeOH, AcOH
85%
O—P
AcHN
O-octyl
(12)
Scheme 3-11: The Synthesis of Sulfate and Phosphate Derivatives of Octyl GlcNAc'
Sulfate (11) was prepared from alcohol (10) using sulfur trioxide trimethylamine 
complex and pyridine. Once the reaction was complete care was talcen to leave the 
compound as the pyiidinium salt as it was observed that complete removal of pyridine 
resulted in decomposition of the sulfonated compoimd. Accordingly removal of excess
’ Sulfonato and phosphonato derivatives were prepaied as their sodium salts. For clarity the 
counter ion has been omitted from this and all subsequent diagrams.
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sulfur üioxide trimethylamme complex from the reaction mixture was achieved by flash 
chromatography on silica gel using methylene chloride/methanol (10:1) with 0 .2% 
pyridine. Directly prior to hydrogenation all the pyiidine was removed from the mixture. 
Hydrogenation was monitored carefully and once the reaction was shown to be complete 
immediate work-up and purification of the compound was carried out. Purification was 
carried out by passing the sulfated compound through a short column of QAE-Sephadex 
AG-25 (anionic) and eluting with sodium chloride (1 M) directly onto a reverse phase C,g 
SepPak cartridge. Elution from the SepPalc yielded the sodium salt of the sulfated sugar
(11), Once the sulfate was converted to the sodium salt the compound appeared to be 
relatively stable and could be stored indefinitely at -20 ” C.
Synthesis of phosphate (12) was achieved using phosphoramidite chemistry [11]. 
Alcohol (10) was treated with dibenzyldiisopropyl phosphoramidite in methylene chloride 
and once formation of the phosphite was complete the reaction mixture was subjected to in 
situ oxidation using m-chloroperbenzoic acid at -40 “ C. This reaction was high yielding 
however it was observed that anhydrous conditions were necessary for the reaction. The 
compound was deprotected by hydrogenation. Work up and purification was similar to that 
for compound (11). Initial attempts to phosphorylate compound (10) using 
tetrabenzylpyrophosphate [12] [13] and also diphenyl phosphorochloridate [14] were 
unsuccessful. This was though to be due to the low reactivity of the 4-OH of N- 
acetylglucosamine.
3.2.4 Synthesis of Siilfate and Phosphate Derivatives of jWAcetyiiactosamine
Chemical coupling using acetobromogalactose (3) as a glycosyl donor and 2- 
acetamido-3,6-di“0-benzyl-P-D-glucopyranoside (10) as a glycosyl acceptor was achieved 
using silver triflate [15] as a promoter (Scheme 3-12).
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p A cAcO
AcO
AcO P A cAcOi. AgOTf, CH2CI2 61%  '
ii. H2, Pd-C, MeOH, AcOH 97% AcO
AcHN
HO O-octylpen
AcO
OHO-octyl (13)
AcHN
(10)
Scheme 3-12: The Synthesis of Disaccharide (13)
Monitoring the reaction by t.l.c. proved problematic due to the large quantities of degraded 
donor present in the reaction mixture. To determine the success of the reaction it was 
necessary to first deacteylate the complex mixture. Degraded donor was then removed by 
flash column chromatography and the mixture was re-acetylated. Diol (13) was then 
obtained by hydrogenation.
Synthesis of the 3-O-sulfonato (IS) and 3-O-phosphonato (16) derivatives of octyl 
LacNAc were carried out as shown in Scheme 3-13.
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PAcAcO AcHN
HO O-octylAcO
AcO BzCl, py/CH2Cl2 (1:5) p A cOH AcO AcHN(13)
88% HO O-octylAcO
AcO
OBz(14)i. SOg.MeaN, py
ii. NaOMe, MeOH i. (BnO)2PN('Pr)2, CH2CI2. 
1-H tetrazole
ii. MCPBA
iii. H2, Pd-C, MeOH, AcOH
iv. NaOMe, MeOH
89%PH 86%HO AcHN
O-octylHO
OH PHHOOH AcHN
O-octylHO
OH
OH(16)
Scheme 3-13: Synthesis of 3-0-8nlfonato (15) and 3-O-Phosphonato (16) Derivatives of
The primary hydroxyl of diol (13) was selectively protected as a benzoate ester. 
Care had to be taken to prevent benzoylation of the 3-OH. Sulfation and phosphorylation of 
alcohol (14) were caiTied out as described for compounds (11) and (12) above, giving rise 
to (15) and (16) on deprotection.
Sulfation of the 6-OH of octyl LacNAc was achieved by a selective sulfation of 
compound (13) using less than 2 mole equivalents of sulfur trioxide trimethylamine 
complex. Deprotection using sodium methoxide yielded the 6-0-sulfonato derivative (17)
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,OAcAcO AcHN
HO O-octyl i. 1.87 eq SC .^Me^N, py 
 ii. NaOMe, MeOHAcO
AcO
97%OH
(13) OHHO AcHN
HO O-octyli. 5 eq SPg.MegN, py
ii. NaOMe, MeOH
HO60%
OH
OHHO AcHN
O-octylHO
OH
(18)
Scheme 3-14: Synthesis of 6-0-SuUbnato (17) and 3,6-Di-0-8nlfbnato (18) Derivatives
off Octyl LacNAc
Synthesis of the 3,6-di-O-sulfonato compoimd (IS) was carried out using five mole 
equivalents of sulfur trioxide trimethylamine complex. However the reaction would not go 
to completion even at elevated temperatures and approximately 40% of the 3-O-sulfonato 
compound (17) was also obtained. Due to instability, separation of these compounds before 
deprotection was difficult by flash column chromatography. Separation of the mono- and 
di-sulfates was achieved on QAE-Sephadex A-25 using a gradient elution with N a tl (0 .02-
0.1 M).
Synthesis of the 6-O-phosphonato derivative (19) was carried out by selective 
phosphorylation of diol (13) using only 1.2 mole equivalents of dibenzyl diisopropyl 
phosphoramidite (Scheme 3-15). Oxidation, deprotection and purification was carried out 
as described for compound (12).
Di-O-phosphorylation of compound (13) was achieved using 5 mole equivalents of 
phosphitylating agent. The 3,6-di-O-phosphonato compound (20) was prepared in high 
yield with no trace of diol (13) or 6-0-phosphonato (19) remaining in the reaction (Scheme
3-15). During purification of the di-O-phosphonato compound it was observed that it had
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less affinity for the Cjg silica gel SepPak cartridges and care had to be talcen to ensure the 
compound was not eluted from the cartridge during washing with water.
ACO
i.l.2 eq (BnO)2PN(Vr)2, CH2CI2.1-H tetrazole
AcHN ii. mCPBA
L - \ ^ 0
" 7 ^ 0
" O-octyl iii. H2, Pd-C, MeOH, AcOH
AcO
OH
" - - . j l ^ O M e ,  MeOH
(13)
“  H O . ™ AcHN
i. 5 eq (BnO)2PN(*Pr)2, 
CH2CI2, 1-H tetrazole 80%
U a —- 0 S2X^""-^^T^O-octylr ^ o
OHii. iii. iv.
(19) ^OPOs^'HO /O H '
AcHNU ^ 0  2-O 3 P O --  - -0 — / y ^ O "O-octyl
OH
(20)
OPO32-
Scheme 3-15: Synthesis off 6-0-Phosphonato (19) and 3,6-Di-O-Phosphonato (20)
Derivatives off Octyl LacNAc
3.2.5 Synthesis off Snlffate and Phosphate Derivatives off Octyl 2-acetamido-2-deoxy-3- 
0-(P-D-gaiactopyranosyi)-p-D-glncopyranoside
Octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-p-D-glucopyranoside (8) was 
coupled with acetobromogalactose (3) using silver triflate as a promoter (Scheme 3-16). As 
for the synthesis of octyl LacNAc, a problem encountered was removal of the degraded 
donor from the reaction mixture. The reaction mixture was deacetylated, purified by 
column chromatography and re-acetylated to yield compound (21).
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O-octyl
AcHN
AcO
AcO (21)
AgOTf, Ct^Clz
OAc 75%AcO O-octyl
AcHNAcO
AcO
80% AcOH, SCPC 68%
OAcOAcAcO
q  HO O-octylAcO
AcHN OHOAcAcO i. CH3 C(OEt)3 , toluene AcO  
J i. 80% AcOH I
AcO^ Q HO O-octylOHOAcAcO AcHNAcOQ AcO (22)O-octylAcO
AcHNAcO
Scheme 3-16: Synthesis of 6-0-Acetyl and 4-O-Acetyl Octyl Gal-p i^-GIcNAc (23)
and (24)
Compound (21) was heated in acetic acid for 2 hours to remove the benzylidene 
acetal to form diol (22). Temporary protection of the diol with an ortho ester [16] followed 
by treatment with acetic acid yielded a mixture of 6-0-acetate (23) and 4-0-acetate (24). It 
was observed that the major product from the reaction was the 6-0-acetate. This can be 
explained by considering the mechanism shown in Scheme 3-17. As for the mechanism for 
reductive opening of benzylidene acetals (Scheme 3-9), which product is favoured depends 
on the relative basicities of the 4- and 6-oxygen atoms.
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OEt,0H,OAcAcO
Q HO O-octylAcO O-octyl
AcHNAcO AcHN
(22)
80% AcOH
OH
< 3-
0-octyl O-octylAcHNAcHN
.OH PACpAc PAcAcO AcO
Q AcO q  HOO-octyl O-octylAcO AcO
AcHN AcHNAcO AcO (23)(24)
Scheme 3-17: The Mechanism of Ortho Ester Cleavage
Alcohol (23) was sulfated and phosphorylated as described for compounds (11) and
(12) to yield compounds (25) and (26) respectively (Scheme 3-18).
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Q HO
AcHN
O-octyl
i. SOa.Me^N, py HO
ii. NaOMe, MeOH
HO
i. (BnO)2PN(*Pr)2, CH2CI2, 
1-H tetrazole
ii. miCPBA
iii. H2, Pd-C, MeOH, AcOH
iv. NaOMe, MeOH
Q -OaSO
AcHN
O/'OsPO
AcHN
O-octyl
O-octyl
(26)
Scheme 3-18: Synthesis of 4-O-SuIfonato (25) and 4-0-Phosphonato (26) Derivatives of
Octyl Gal-P-l^-GlcNAc
Alcohol (24) was converted to its corresponding 6-O-sulfonato (27) and 6-0- 
phosphonato (28) derivatives (Scheme 3-19) as described for the conversion of (10) to (11) 
and (12).
pH pHPAc i. SO;.Me^N, py
ii. NaOMe, MeOH
HOAcO
HOQ AcO O-octylAcO O-octyl88%AcHN OHAcO AcHN(24) (27)
99%i. (BnO)2PN0Pr)2, CHgClg, 
1-H tetrazole
ii. wjCPBA
iii. H%, Pd-C, MeOH, AcOH
iv. NaOMe, MeOH
PHHO
HO
HO O-octyl
OH AcHN
Scheme 3-19: Synthesis of 6-0-Snifonato (27) and 6-O-Phosphonato (28) Derivatives of
Octyl Gal-p-W-GlcNAc
The 4,6-di-O-sulfonato (29) and phosphonato (30) derivatives of octyl Gal-p-1,3- 
GlcNAc were prepared from diol (22) as described for compounds (18) and (20) (Scheme
3-20).
AcO OAc i. SOg.MeaN, py HO ^ .OSO3-1 < \  ^  ii. NaOMe, MeOH 1 <
— ^ -Oaso-^
AcO --\ hoA O-octyl
AcO AcHN OH AcHN(22) (29)
i. (BnOhPNfPrh.
l-H tetrazole HO /O H yOPOa^'
ii. wCPBA "  u ïl^O ^'O aP O -^
iii. Hz, Pd-C, MeOH, AcOH H O A . O-octyl
iv. NaOMe, MeOH OH AcHN
(30)
Scheme 3-20: Synthesis of 4,6-Di-0-8nlfbmato (29) and 4,6-Dl-O-Phosphonato (30)
Derivatives of octyl Gal-p i^-GlcNAc
3.2.6 Characterization of Snifbnato and Phosphonato Derivatives
Sulfated and phosphorylated sugars (15-30) were characterized by and n.m.r. 
spectroscopy and FAB or ES mass spectroscopy. Due to the nature of these compounds 
elemental analysis proved to be unsuccessful and on determining melting points, 
decomposition occurred. Optical rotations in all cases were less than 2° (c 0.1, MeOH). 
Octyl LacNAc (31) and octyl Gal-^-l ,3-GlcNAc (32) were prepared by deacetylation of 
compounds (13) and (22) respectively using sodium methoxide in methanol.
Chaiacteristic 'H n.m.r. shift changes induced by substitution in the N- 
acetyllactosamine series of sulfates and phosphates are shown in Figure 3.1. An interesting 
obseivation is the down field shifts of the Hj. signal in the compounds containing a sulfate 
moiety at position 3 of the disaccharide. This is likely to be due to an overall change in 
orientation of the pyranose rings relative to one another induced by the steric effects of 
substitution at the site adjacent to the glycosidic linkage [6], This torsional effect caused by 
sulfation at sites adjacent to glycosidic linlcages has also been shown to occur for 
chondroitin sulfate related disaccharides [17]. A similar pattern can be observed for the
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corresponding sugars containing a phosphonato moiety at position 3. Similarly Figure 3.2 
shows the n.m.r. data for all octyl Gal-p-l,3-GlcNAc sulfates and phosphates.
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octyl LacNAc
H3
3 - C>-sul£ate
Ml
3-O-pliosphate
J \ f \«S-O-svilfate
6-O-pliospliate
3 , 6 - c J i - O - s u l f a t e
HiHI' H3, H6a, H6b
4 . 6
3,6-di- O-pliosphate
Figure 3.1: H N.M.R. Data of Octyl LacNAc Sulfates and Phosphates
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H i
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Figure 3.2: N.M.R. Data of Octyl Gal-p-l,3-GlcNAc Sulfates and Phosphates
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galactùpyramsyl)-P-D'-glMcospyrano§îde (3 7)
It has been shown that for some glycosyltransferases replacement of the hydroxyl to 
be glycosylated of the acceptor substrate with an amino group produces an inhibitor of the 
enzyme (Chapter 1). It is thought that rather than a hydrogen bond interaction with the 
active site base of the enzyme and the hydroxyl group of the acceptor, a charge-charge 
interaction results with the protonated form of the amino compound. To determine whether 
the 3-amino compound was an inhibitor of a -1,3-fucosylti'ansferases it was decided to 
prepare octyl 2-acetamido-3-amino-2-deoxy-4-0-(P-D-galactopyranosyl)-p-D- 
glucopyranoside (37). The synthesis of the acceptor substrate for chemical coupling is 
shown in Scheme 3-21.
M3C».b.3N.ch,c.,^
AcNHAcNH(8)
NaOAc, H2O, 
2-methoxyethanoI
(33)
98%
MsCl, EtgN, CH2CI2
I AcNH MsO
(35)
0 -octyl
72% I AcNH OH
(34)
NaN), DMF
Ph^ " ^ 0  O " N3
70%
TFA, EtsSiH, CH2CI2
0 -octyl 94% ^  HO
AcNH
(36)
AcNH
0 -octyl
Scheme 3-21: Synthesis off Octyl 2-AcetamMo-3-az:do-2-deoxy-p-D-gMcopyranoside
(37)
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The alcohol (8) was sulfonylated using a procedui-e described by Vasella and co-workers 
[18] using methanesulfonyl chloride and triethylamine in methylene chloride (Scheme 3- 
21). The alcohol was insoluble in methylene chloride but dissolved on addition of the 
methanesulfonyl chloride. The reaction was complete within 0.5 h. Inversion of the 
stereochemistry at position 3 of octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-3-0- 
methanesulfonyl-p-D-glucopyranoside (33) was achieved using a method described by 
Jeanloz [19]. The sulfonylated compound (33), sodium acetate and water in 2- 
methoxyethanol were refluxed for 20 hours under argon. The mechanism for the reaction is 
shown in Scheme 3-22 and fii'st involves an 8^2 displacement of the methanesulfonate 
group by acetate anion. The hydroxyl group of 2-methoxyethanol attacks the acetate group 
to leave the unprotected alcohol octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-p-D- 
allopyranoside (34) in 98% yield.
O-ootyl O-octyl
AcNH AcNH
(31)
Na OAc
HO OMe
O-octyl
AcNHOH
(32)
Scheme 3-22: Mechanism of Mesylate Displacement
The ût//o-configured alcohol (34) was sulfonylated to give octyl 2-acetamido-3-0- 
methanesulfonyl-4,6-0-benzylidene-2-deoxy-P-D-allopyranoside (35) as described for the 
g/wco-isomer. Azide (36) was obtained by heating (35) in DMF with sodium azide at 110°C
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as described by Wong and co-workers [20]. Selective reduction of the benzylidene acetal of 
compound (36) was achieved using trifluoroacetic acid and triethylsilane in methylene 
chloride [8]. An interesting observation is the relatively high yield obtained for this 
reduction compared to that obtained for the same reaction with octyl 2-acetamido-3-0 - 
benzyl-4,6-C>-benzylidene-P-D-glucopyranoside (10). The reductive ring opening of the 3- 
azido sugar proved to be high yielding and no side products were isolated from the reaction 
mixture. Perhaps for compound (10) the incoming electrophile is also coordinated by the 
benzyl group oxygen at the 3 position of the sugar and hence a competing reaction would 
be the formation of the 6-OH compound.
Attempts were made to chemically couple alcohol (37) with acetobromogalactose 
(3). However despite attempts at numerous different glycosylation methods (halide/AgOTf, 
halide/HgBrj, imidate/BFjOEtj and imidate/Ig) including those successfully used for 
chemical coupling of the 3,6-di-O-benzyl protected sugar (10) no formation of the desired 
compound was obseiwed. This may be due to the steric bulk of the azido group at the site 
adjacent to the hydroxyl to be glycosylated.
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4.1 General Details
t.l.c. was performed on silica gel 60 GF254 (Merck) and compounds were detected 
with UV light or charring with dilute sulfuric acid or orcinoT as appropriate. Flash-column 
chromatography was performed on silica gel 60 (230-400 mesh, Merck). %  and 
n.m.r. spectra were recorded on a Varian Gemini 300 spectrometer (300 MHz, FT H  
n.m.r.; 75 MHz, FT "C n.m.r.; 121 MHz, FT ^'P n.m.r.) usually using deuteriochloroform 
as the solvent and TMS as an internal standard for H  and spectra and usually using 
deuterium oxide as a solvent and phosphoric acid as an external reference for ^^ P spectra. J  
values aie given in Hz. M.p.s were determined on an Electrothermal melting point 
apparatus and are unconected. Elemental microanalyses were performed by the 
departmental microanalysis laboratory. Mass spectra were recorded by FAB-MS (using 
Clellands Matrix) or ES-MS as stated. I.R. spectra were recorded on a Perkin-Elmer 1710 
FT IR spectrometer. Samples were typically prepared as a Nujol mull between sodium 
chloride discs. The frequency (v) of absorption maxima are given in wavenumbers (cm *) 
relative to a polystyrene standard. All the solvents used were either distilled or AnalaR 
quality. Solvents were dried according to literatuie procedures [1]. CHjClj and toluene were 
distilled from CaHj. THF was distilled from sodium/benzophenone under Nj. All solid 
reagents were dried over P2O5 overnight in vacuo prior to use. Sodium hydride was used as 
a 60% dispersion in oil, which was washed with hexane immediately before use. mCPBA 
was used at 50% purity. Anhydrous hydrogen chloride gas was generated by dripping 
concentrated sulfuric acid onto anhydious NaCl in a two-neck round bottom flask. The gas 
generated was dried by passage through a Drechsel bottle containing calcium chloride. 
Reverse phase C^ g SepPak cartridges (0.5 cm  ^ Waters, part no. WAT020515) were 
equilibrated before use by washing with HjO (10 cm^), MeOH (10 cm^) and H2O (10 cm )^. 
Extraction procedures were carried out by diluting with CHgClg and washing sequentially 
with saturated aqueous NaHCOa solution and HgO. For procedures using pyridine the 
solution in CHjClj was first washed with 2M HCl. Organic extracts were dried using either 
anhydrous NazSO  ^or MgSO^.
" Orcinol spray was used for detecting low concentrations of deprotected sugars, and was prepared as follows: 
orcinol monohydrate (0.36g) was diluted in H^ O (lOcm^). H2 SO4  (20cm )^ and EtOH (ISOcm )^ were added.
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2,3,4,6-Tetra-O-acetyUa-D-galactopyranosyl bromide (3).
To an ice-cold solution of D-galactose (10.96 g, 60.9 mmol) and DMAP in pyridine 
(20 cm^) was added acetic anhydride (35 cm \ 371 mmol) and the solution was stirred at r.t.. 
Once t.l.c. (toluene-EtOAc, 3:1) showed the reaction to be complete CHjClj (150 cm^) was 
added and the solution was subjected to a standard work-up to give galactopyranose 
pentaacetate as an a/p  mixture which was used directly in the next step.
To a solution of galactopyranose pentaacetate (18.35 g, 470 mmol) and acetic 
anhydride (1 cm^) in CH2CI2 (50 cm^) was added HBr (18 cm \ 30% w/v solution in AcOH) 
and the solution was stirred for 2 h. The mixture was concentrated and AcOH was removed 
by co-evaporation with toluene to give an oil which was subjected to a standard work up. 
Flash chromatography of the resulting residue (toluene-EtOAc, 3:1) yielded an immobile 
oil which was crystallised to give the title compound as white needles (8.22 g, 43%); m.p. 
83-85 "C (EtzO), Lit. [2] 84-85 "C; [aj^ +200 (c 0,1, CHCI3), Lit. [a]^ +217 (c 1, CHCI3); 
6h (CDCI3) 2.01 (3 H, s, O^c), 2.06 (3 H, s, O^c), 2.11 (3 H, s, OWc), 2.15 (3 H, s, OWc), 
4.15 (2 H, m, 6-H, 6'-i7), 4.48 (1 H, m ,5 -^ , 5.05 (1 H, dd, 7.0 and „ 3.9 Hz, 3-H), 
5.40 (1 H, dd, J ,,2 3.5 Hz and J 2.3 2-H), 5.52 (1 H, m, 4-H), 6.70 ( 1 H, d, 1-7^.
2-Acetamido-3,4,6~tri-0-acetyl-2-deoxy-a-D-glucosylpyranosyl chloride (5)
Compound (§) was prepared using the procedure described by Horton [2]. Acetyl 
chloride (20 cm^) was saturated with anhydrous HCl gas and added slowly to /V-acetyl 
glucosamine (11.29 g, 51 mmoles). The suspension refluxed spontaneously during the first 
hour of the reaction. The solution was allowed to stir for 24 h until t.l.c. (toluene-EtOAc, 
4:1) showed the reaction to be complete. The reaction mixture was diluted with CHjClj (80 
cm^) and the solution was poured with stirring onto ice (80 g) and H2O (20 cm^). The 
phases were separated and the organic phase was run off into iced saturated NaHCOj 
solution (80 cm^). The organic phase was separated, washed with saturated NaHCOj 
solution, and run directly into a flask containing anhydrous MgSO^. The solution was 
filtered and the filtrate was concentrated until only a small amount of CH2CI2 was left (10 
cm^). EtjO (200 cm^) was added and white needles of (5) formed spontaneously (12.65 g, 
68%); m.p.l25-127”C Lit [2] 127-128 "C; [aj^ +105 (c 0.1, CHCI3), Lit. [2] [ a ^  +110 (c
1.1, CHCI3) ; 0„ (CDCI3), 1.99 (3H, s, NH4c), 2.05 (6H, 2xs, OAc), 2.10 (3H, s, OAc),
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4.21-4.33 (3 H, m, 5-H, 6-H, &-H), 4,53 (1 H, ddd, 3.7, J2.3 9.6, Jj.nh 8.8 Hz, 2-/7), 5.21 
(1 H, t, J9 .5  Hz, 3-H/4-H), 5.33 (1 H, t, J9.5 Hz, 3-H/4-H), 5.85 (1 H, br d, J 8.8 Hz, N/7), 
6.18(1 H, d ,/j,2» 1-H).
Octyl 2~acetamido-3,4,6-tri-0-acetyl-2-deoxy-p-D-glucopyranoside (6).
The title compound was prepared using a Koenigs-Knorr coupling procedme as 
described by Lemieux and co-workers [3]. To a suspension of Hg(CN)2 (410 mg, 1.63 
mmol), HgBij (55 mg, 0.15 mmol) and anhydrous CaSO^ (1.11 g) in anhydrous toluene (1 
cm^) was added octanol (0.5 cm ,^ 2.84 mmoles). The flask was flushed with Nj while 
Stirling for 1 h. 2-Acetamido-3,4,6-tri-0-acetyl-2-deoxy-a-D-glucopyranosyl chloride (S) 
(507 mg, 1.39 mmoles) was added and the mixtuie was stirred at r.t. for 4 days. CHgCl; (50 
cm^) was added and solids were removed by filtration through Celite. The filtrate was 
subjected to a standard worloip and puiified by flash chromatography (silica gel; toluene- 
EtOAc, 1:1) affording compound (6) as a white solid (0.48 g, 75%); m.p. 125-128 “C; [ajp 
-12.6 {c 0.1, CHCI3); (Found C, 57.70; H, 8.24; N, 3.00. C20H3A N  requires C, 57.50; H, 
8.11; N, 3.05.); 0„ (CDCI3), 0.6-1.5 (15 H, 3 x m, octyl H), 1.95 (3 H, s, NHXc), 2.03 (3 H, 
s, 0Æ ), 2.04 (3 H, s, OAc), 2.09 (3 H, s, OAc), 3.46 (1 H, m, -OC//2 of octyl chain), 3.70 (1 
H, m, 5-/7), 3.83 (2 H, m, -OC/Zj of octyl, 2-/7), 4.12 (1 H, dd, 2.5 and 12.2 Hz, 6- 
/7), 4.27 (1 H, dd, Jj,,. 4.6 Hz and &-H), 4.69 (1 H, d, 8.3 Hz, 1-/7), 5.07 (1 H, t, J
9.8 Hz, 3-77/4-//), 5.32 (1 H, t, J9 .8  Hz, 3-/7/4-/T), 5.49 (1 H, br d, J 8.8 Hz, N/7).
Octyl 2-acetamido-2-deoxy-P-D-glucopyranoside (7)
To a solution of octyl 2-acetamido-3,4,6-tri-0-acetyl-2-deoxy-p-D-glucopyranoside
(6) (5 g, 11 mmoles) in MeOH (20 cm^) was added a small piece of sodium and the solution 
was left to stand at r.t. for 4 h. Amberlite IR-120 (H^) ion exchange resin (5 g) was added 
and the mixture was stirred for 5 mins. The resin was removed by filtration, washed with 
MeOH, and the filtrate was concentrated to dryness to give the title compound as an 
amorphous solid (3.48 g, 96%); 6  ^ (CD3OD) 0.6-1.5 (15 H, 3 x m, octyl 77), 1.98 (3 H, s, 
NH4c), 3.31-4.26 (m, 2-6-77), 4.39 (1 H, d, J ,.2 8.4 Hz, 1-/7); FAB-MS: Calcd for 
[CifiHjiNOfi] 333.1 obs: m/z: 356.0 [M + Na], 334.2 [M + 1].
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Octyl 2~acetamido~4,6-0-benzylidene~2-deoxy-p-D-glucopyranoside (8)
To a solution of octyl 2-acetamido-2-deoxy-p-D-glucopyranoside (7) (6.13 g, 18.4 
mmoles) and p-TsOH (123 mg, 0.6 mmoles) in anhydrous CH3CN (120 cm^) was added 
benzaldehyde dimethyl acetal (4.42 cm \ 29.4 mmoles). Almost immediately the starting 
material started to dissolve and a white solid subsequently precipitated from the reaction 
mixture. The reaction was shown to be complete by t.l.c. (toluene-EtOAc, 2:1) after 10 
mins. EtaN (0.075 cm ,^ 2.5 eq with respect to p-TsOH) was added to quench the reaction. 
Water was added and the solid obtained was removed by filtration, washed with HgO, and 
dried over NagSO .^ Crystallization gave the title compound as white needles (6.08 g, 78%); 
m.p. 218-220"C (EtOH); [aj^ -56 (c 0 .1, MeOH); (Found C, 65.88; H, 8.52; N, 3.28. 
C23H35O6N requires C, 65.53; H, 8.37; N, 3.32.); 3265 (OH), 2925 (NH), 1685 (CO); 6»
(CDCI3); 0.6-1.5 (15 H, 3 X m, octyl H), 2.0 (3H, s, NH4c), 3.3-3.6 (3 H, m), 3.7-4.0 (2 H, 
m), 4.1-4.4 (2 H, m), 4.72 (1 H, d, J,,; 8.2 Hz, 1-/7), 5.56 (1 H, s, ArCTT), 5.72 (1 H, br d, J
8.6 Hz, N/7), 7.39 (5 H, m, Ar).
Octyl 2-acetamido-3-0-benzyl-4,6-0-benzylidene-2-deoxy~p~D-glucopyranoside (9)
Benzyl bromide (0.03 cm ,^ 0.28 mmoles) was added to an ice cold solution of octyl
2-acetamido-4,6-0-benzylidene-2-deoxy-p-D-glucopyranoside (8) (100 mg, 0.237 mmoles) 
in DMF (5 cm^). Sodium hydride (3 mg, 0.3 eq) was added every 30 mins until t.l.c. 
(toluene-EtOAc, 2:1) showed the reaction to be complete. Ice-water was added to 
precipitate the product, which was collected by filtration and washed with HjO. Flash 
chromatography (toluene-EtOAc, 2:1) gave the title compound as white needles (97 mg, 
61%); m.p. 216-218 "C; [a]^ -4 (c 0.1, CHCI3); (Found C, 70.97; H, 8.71; N, 2.76. 
CaAiOgN with 1 mol EtOH, C, 70.69; H, 8.71; N, 2.58.); 3265 (NH), 1655 (CO); 0»
(CDCI3), 0.6-1.5 (15 H, 3 X m, octyl 77), 1.87 (3 H, s, NH^c), 3.2-3.9 (6 H, m), 4.34 (2 H, 
m), 4.65 (1 H, d, J  12.0 Hz, ArC/Q, 4.90 (1 H, d, J  12.0 Hz, ArC/Z^), 5.00 (1 H, d, 2 8.3 
Hz. 1-77), 5.56 (1 H, br d, J8 .0  Hz, N/7), 5.58 (1 H, s, ArC/7), 7.39 (10 H, m, Ar),
Octyl 2-acetamido-3,6-di-0-benzyl~2-deoxy-P-D-glucopyranoside (10)
(a) Compound (10) was prepared using a selective acetal ring opening procedure 
described by Garegg and co-workers [4]. To an ice-cold suspension of octyl 2-acetamido-3-
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0-benzyl-4,6-0-benzylidene-2-deoxy-P“D-glucopyranoside (9) (300 mg, 0.58 mmol), 
sodium cyanoborohydride (364 mg, 5.28 mmol) and powdered 4Â sieves and a crystal of 
methyl orange in THF was added a saturated solution of HCl in EtgO to acidify the reaction 
mixture. Once t.l.c. (toluene-EtOAc, 1:1) showed the reaction to be complete, ice-water was 
added and the solution was subjected to a standard work up. Flash chromatography 
(toluene-EtOAc, 2:1) gave a solid which was crystallised to give the title compound as 
white needles (170 mg, 57%); m.p. 116-118 "C (EtOAc/hexane); [aJo -17 (c 0.1, CHCI3); 
(Found C, 70.05; H 8.64; N, 2.70. C30H43O6N requires C, 70.15; H, 8.44; N, 2.73); 0  ^
(CDCI3), 0.6-1.5 (15 H, 3xm, octyl H), 1.91 (3 H, s, NH4c), 3.2-4.0 (6 H, m), 4.04 (1 H, dd, 
J ),4 and ^4,5 8.2 Hz, 3-H), 4.S-4.7 (7 H, m), 4.86 (1 H, d, 8.2 Hz, 1-H), 5.57 (1 H, br d, /  
7.7 Hz, N/7), 7.30 (10 H, br s, Ar).
b) Compound (10) was prepared using a selective acetal ring opening procedure 
described by DeNinno and co-workers [5]. To an ice-cold suspension of octyl 2-acetamido-
3-0-benzyl-4,6-0-benzylidene-2-deoxy-P-D-glucopyranoside (9) (500 mg, 0.97 mmol) and 
triethylsilane (0.77 cm \ 4.86 mmol) in CHgCl  ^ (5 cm^) was added TFA (0.37 cm ,^ 4.86 
mmol) dropwise. The solution was allowed to warm to r.t. Once t.l.c. (toluene-EtOAc, 1:1) 
showed the reaction to be complete (4 h), EtOAc was added and the solution was subjected 
to a standard work up. The product was purified by flash chromatography (toluene-EtOAc, 
2 :1) to afford the alcohol (30) as white needles (300 mg, 60%). Analytical data were 
identical to those obtained previously. I
Octyl 2~acetamido-2-deoxy-4-Osulfonato-fi-D~glucopyranoside (11)
Alcohol (10) (200 mg, 0.4 mmol) was dissolved in pyridine (20 cm^) and sulfur 
trioxide-trimethylamine complex (200 mg, 1.5 mmol) was added. The suspension was left 
to stir for 20 h. MeOH (1 cm^) was added and the mixture was concentrated to dryness and 
purified by flash column chromatography (CHgCl; / MeOH 10:1 containing 0.2% v/v 
pyridine). The oil obtained was immediately dissolved in MeOH (20 cm^) and palladium 
(5% on charcoal) (100 mg) was added. The suspension was acidified with AcOH and stirred 
under Hj for 4 h. Filtration through Celite followed by concentration to dryness yielded the 
title compound as the free acid. Conversion to the sodium salt was achieved by passage 
through QAE-Sephadex A-25 (OH ) and elution with NaCl solution (IM) (3x5 cm^) directly
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onto a Ci8 SepPalc. Washing with water (5 cm^) followed by elution with MeOH (10 cm )^ 
and evaporation yielded the title compound as the sodium salt which was freeze dried from 
H2O (128 mg, 75%); 6» (D^O), 0.5-1.6 (15 H, 3xm, octyl H), 1.94 (3 H, s, NKMc), 3.Ô-3.7 
(2 H, m, 3-/7, -00/72  of octyl), 3.8-3.9 (3 H, m, 5-/7, 2-/7, 6-/7), 4.00 (1 H, m, -OCH^ of 
octyl), 4.06 (1 H, dd, 12.6 an d ^  ^ . 2.3 Hz, 6’-/7), 4.24 (1 H, t, 9.1 Hz, 4-/7), 4.63 (1 
H, d, J12 8.4 Hz, 1-/7); ôc (D^O), 11.5, 20.1, 20.3, 23.2 (2x0), 26.4, 26.6, 29.2, 53.5, 58.7,
68.6, 70.4, 72.4, 75.2, 99.1, 172.5 (0=0); FAB-MS: Oalcd for [O^AoNOgS.Na], 430.21 
obs: m/z 457.9 (M+Na).
Octyl 2-acetamido-2-deoxy-4-0-phosphonato~l3-D-glucopyranoside (12)
To a mixture of alcohol (10) (140 mg, 0.27 mmol) and l-/7tetrazole (80 mg, 0.82 
mmol) in OHgOlg (10 cm^) was added W,7V-diisopropyldibenzyl phosphoramidite (0.14 cm\ 
0.41 mmol). The reaction was stirred at r.t. until t.l.c. (toluene/EtOAc, 2:1) indicated the 
reaction to be complete (2 h). The mixture was cooled to -40 ° 0  and wOPBA (90 mg, 0.54 
mmol, 50% purity) in OH2OI2 (5 cm^) was added. The resulting solution was stirred at 0 ° 0  
for 0.5 h, diluted with OHjOlj (40 cm^), washed with aqueous NagSO  ^ (10%, 2x20 cm^), 
saturated aqueous NaHOOj solution (2x15 cm^) and saturated aqueous NaOl solution (20 
cm )^. The organic extract was dried over NagSO ,^ concentrated to diyness and pmified by 
flash column chromatography (toluene/EtOAc, 2:1). The oil obtained was immediately 
dissolved in MeOH (20 cm^) and palladium (5% on charcoal, 100 mg) was added. The 
suspension was acidified with AcOH and stiired under Hg for 4 h. Filtration through Oelite 
followed be concentration to dryness yielded the title compound as the free acid. 
Conversion to the sodium salt was achieved by passage through QAE-Sephadex A-25 (OH 
) and elution with NaCl solution (IM) (3x5 cm^) directly onto a C,g SepPalc. Washing with 
water (5 cm^) followed by elution with MeOH (10 cm^) and concentration to dryness 
yielded the title compound as the sodium salt which was freeze dried from HjO (105 mg, 
85%); ÔH (D2O), 0.6-1.5 (15 H, 3xm, octyl H), 2.13 (3 H, s, NH4c), 3.61 (1 H, m, 5-/7), 
3.69 (1 H, m, 0C/7J, 3.8-3.9 (3 H, m, 4-/7,2-/7, 6-/7), 3.98-4.04 (2 H, m, 3-/7, 6'-/7), 4.61 
(1 H, d, /,,2 8.2 Hz, 1-/7); 0c(D20) 13.3, 21.9, 22.1, 25.0, 28.3, 28.4, 28.5, 31.0, 55.3, 60.6,
70.5, 73.0, 73.7, 75.3, 101.2; 6p (DjO) 0.9; FAB-MS: Calcd for [C^AoNOgP.Na^] 457.0 
obs: m/z 435.8 (M-Na), 457.8 (M).
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Octyl 2-acetamido-4-0-(2,3,4,6~tetra-0-acetyl-/3-D-galactopyranosyl)-2-deoxy-P-D- 
glucopyranoside (13)
A solution of alcohol (10) (750 mg, 1.5 mmol ) and bromide (3) (1.2 g, 2.9 mmol) 
in CHjClj (20 cm^) containing powdered 4Â sieves (2 g) was stirred under Ng for 3 h and 
cooled to -30 “C. AgOTf (1.12 g, 4.4 mmol) was added and the suspension was stirred until 
t.l.c. (CHjClz/MeOH, 15:1) indicated the reaction to be complete. Collidine (0.9 cm\ 5 
mmol) was added and solids were removed by filtration through Celite. The filtrate was 
subjected to a standard workup, dried over NagSO  ^and concentrated to dryness. The residue 
obtained was dissolved in MeOH (25 cm^) containing palladium (5% on charcoal, 150 mg) 
and subjected to hydrogenation until t.l.c. (toluene/EtOAc, 1:1) indicated the reaction to be 
complete (5 h). The suspension was filtered through Celite and the filtrate was concentrated 
to dryness. Flash chromatography (toluene/EtOAc, 1:1 0:1) yielded the title compound
as a white solid (610 mg, 63%); m.p. 140-142 “ C; [a]o <2 (c 0.1, CHCI3); (Found C, 53.97; 
H, 7.61; N, 2.22. C^ oH^ pOigN requires C, 54.29; H, 7.44; N, 2.11.); 6» (CDCI3), 0.6-1.5 (15 
H, m, octyl H), 1.92 (3 H, s, NHXc), 1.93 (3 H, s, OWc), 2.00 (3 H, s, OAc), 2.04 (3 H, s, 
OAc), 2.90 (3 H, s, OAc), 3.3-3.4 (3 H, m), 3.5-S.6 (2 H, m), 3.7-3.S (2 H, m), 3.9-4.2 (4 
H, m), 4.63 (1 H, d, 7.9 Hz, 1-/7), 4.71 (1 H, d, / 1..2. 7.9 Hz, V-H), 4.98 (1 H, dd, ^ . 3,
10,4 andJ^.,4. 3.7 Hz, 3'-//), 5.15 (1 H, dd,.^,^. and/j ^ -, 2*-/7), 5.32 (1 H, m, 4'-B), 5.57 (1 
H, brd, 7.5 Hz, N/7).
Ociyl 2-acetamido-4-0-(2,3,4,6-tetra-0-acetyl-/TD-galactopyranosyl)-6-0-benzoyl-2- 
deoxy -fi-D glucopyranoside (14).
Diol (13) ( 250 mg, 0.38 |imol ) was dissolved in pyridine-CH^Clg (1:5 v/v, 8 cm^) 
and cooled on an ice bath. BzCl (0.05 cm ,^ 0.47 pmol) was added and the mixture was 
allowed to warm to r.t. Once t.l.c. (EtOAc) indicated the reaction to be complete (3 h) 
MeOH was added and the solution was concentrated to dryness. Silica gel chromatography 
(toluene toluene/EtOAc 1:1) gave (14) as a colourless solid (255 mg, 88%); 0^ (CDCI3), 
0.6-1.5 (15 H, 3xm, octyl H), 1.89 (3 H, s, OAc), 1.94 (3 H, s, O^c), 2.00 (3 H, s, OAc),
2.09 (3 H, s, m U c), 32-3.6 (3 H, m), 3.6-3.8 (3 H, m), 3.8-4.1 (3 H, m), 4.23 (1 H, dd,
12 and 5.4 Hz, 6a-/7), 4.53 (1 H, d, 7.8 Hz, l-H), 4.75 (1 H, d, 8.1 Hz, l ’-/7),
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4,88 (1 H, dd, ^.,4. 3.3 andJ,.,. 10.5 Hz, V-H), 5.17 (1 H, dd, ^ . 3. and 2’-/7), 5.30 (1 
H, d, J^.4., 4^-H), 5.61 (1 H, d, J8 .2  Hz, NH), 7.2-7.4 (3 H, m, Ar), 7.96 (2 H, m, Ar).
Octyl 2-acetamido-2-deoxy-4-0-(p-D-galactopyranosyl)-3-0-sulfonato-p-D 
glucopyranoside (15).
Sulfation was carried out as described for compound (11) using alcohol (14) (130 
mg, 0.17 mmol), pyridine (10 cm^) and sulfur trioxide-trimethylamine complex (68 mg, 
0.49 mmol). The oil obtained was dissolved in MeOH (20 cm^) and NaOMe (30 mg) in 
MeOH (5 cm^) was added. The reaction was stirred at r.t. for 4 h and Amberlite IR-120 (H )^ 
was added until neutralisation had occurred. Concentration to dryness and purification of 
the desired product was carried out as described for compound (11), yielding (IS) as a 
white solid (90 mg, 89%); 0» (D^O), 0.6-1.5 (15 H, m, octyl H), 1.88 (3 H, s, NHXc), 3.3-
3.9 (11 H, m), 4.05 (1 H, dd, 10.3 a n d 2.1 Hz, 6a-H), 4.45 (1 H, d, Hz, 1- 
H), 4.49 (1 H, dd, ^,3 10.3 and J34 8.9 Hz, 3-H), 4.65 (1 H, d, Jj-j. 8.2 Hz, I'-H); 8  ^(D^O),
13.3, 22.0, 22.4, 25.0, 28.3, 28.5 (2xC), 31.1, 54.7, 60.0, 61.0, 68.9, 70.7, 71.1, 72.9, 75.1 
(2xC), 75.9, 79.3, 100.5, 103.3; FAB-MS: Calcd for [C22H40NO.4S.Na] 597,61 obs: m/z
619.8 (M+Na).
Octyl 2-acetamido-2-deoxy-4-0-(/3~D-galactopyranosyl)-3-0-phosphonato-/3-D 
glucopyranoside (16).
Phosphorylation of alcohol (14) was carried out as described for compound (12) 
using alcohol (14) (100 mg, 0.13 mmol), l-H  tetrazole (30 mg, 0.39 mmol), N,N- 
diisopropyldibenzyl phosphoramidite (0.065 cm^ 0.19 mmol) and mCPBA (50 mg, 0.26 
mmol). The oil obtained was dissolved in MeOH (20 cm^) and palladium (5% on charcoal, 
100 mg) was added. The suspension was acidified with AcOH and stirred under Hg for 4 h. 
The reaction mixture was filtered through Celite, concentrated to dryness and dissolved in 
MeOH (20 cm^). NaOMe (50mg) in MeOH (5 cm^) was added and the solution was left to 
stir at r.t. for 4 h. Amberlite IR-120 (H^) was added until neutralisation had occurred. 
Evaporation and purification of the desired product was carried out as described for 
compound (11) yielding (16) as a white solid (69 mg, 86%); 8» (DjO), 0.6-1.5 (15 H, 3xm, 
octyl H), 1.91 (3 H, s, NH/fc), 3.4-3.8 (11 H, m), 4.05 (1 H, dd, 12 and 2.3 Hz,
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6a-H), 4.24 (1 H, dd, J34 9.8 and ^ 310.4 Hz, 3-H), 4.51 (1 H, d, 7.5 Hz, l-H), 4.60 (1 
H, d, J;,;, 8.1 Hz, r-H); ôc (D fi), 13.4, 22.0, 22.4, 25.0, 28.3, 28.5 (2xC), 31.1, 55.2, 60.0, 
60.9, 68.7, 70.6, 70.9, 72.6, 75.1, 75.6, 76.1, 77.4, 100.8, 103.5; ôp (D^O) 3.2; FAB-MS: 
Calcd for [CzzH i^NOi^P.Na^] 619.5 obs: m/z 620.2 (M+1).
Octyl 2-acetamido-2-deoxy~4-0-(P-D-galactopyranosyl)-6-0-sulfonato-P-D 
glucopyranoside (17).
Sulfation of 6-OH of diol (13) was carried out as described for sulfate (11) using 
diol (13) (50 mg, 0.07 mmol), pyridine (2 cm^) and sulfur trioxide-trimethylamine complex 
(20 mg, 0.14 mmol). Deprotection and purification of sulfate (17) was carried out as 
described for sulfate (IS). The title compound was obtained as a white solid (44 mg, 97%); 
ÔH (DgO), 0.6-1.5 (15 H, 3xm, octyl H), 1.91 (3 H, s, NH4c), 3.35-3.90 (12 H, m), 4.32 (1 
H, dd, 11.3 and 4.1 Hz, 6b-H), 4.43 (1 H, dd, and Jsm 1 -2 Hz, 6a-H), 4.57 (I H, 
d, 6.4 Hz, l-H), 4.59 (1 H, d, 5.8 Hz, I'-H); ôc (D^O), 13.4, 22.0, 22.2, 25.04, 28.3,
28.5 (2xC), 31.1, 55.2, 61.1, 66.4, 68.7, 70.7, 71.1, 72.4, 72.6, 75.4, 77.6, 101.2, 102.6,
174.6 (C=0); ES-MS: Calcd for [Cz^H^iNO^S] 574.61 obs: m/z 573.7 (M-1).
Octyl 2-acetamido-2-deoxy-'4-0-(j3-D-galactopyranosyl)-3,6-di-0-sulfonato-/TD 
glucopyranoside (18).
Sulfation of 6-OH of diol (13) was carried out as described for sulfate (11) using 
diol (13) (70 mg, 0.1 mmol), pyridine (5 cm^) and sulfirr trioxide-trimethylamine complex 
(120 mg, 0.84 mmol). Deprotection and purification of the residue obtained was carried out 
as described for sulfate (IS). The title compound was obtained as a white solid (43 mg, 
60%); ÔH (DjO), 0.6-1.5 (15 H, m, octyl H), 2.01 (3 H, s, NR4c), 3.5-3.S (5 H, m), 3.8-4.0 
(5 H, m), 4.43 (1 H, dd, 11.2 and ^,g,4.3 Hz, 6a-H), 4.50 (3 H, m, 6b-H, 3-H, l-H), 
4.68 (1 H, d, 8.7 Hz, I'-H); ES-MS: Calcd for [Cg^H i^NO^Sz] 654.67 obs: m/z 327.4 
(M").
81
Octyl 2-acetamido-2-deoxy-4-0-(P~D-galactopyranosyl)-6-0‘phosphonato-p-D 
glucopyranoside (19).
Phosphorylation of the 6-OH of diol (13) was carried out as described for phosphate 
(12), using alcohol (13) (50 mg, 0.07 mmol), l-H  tetrazole (13 mg, 0.18 mmol), N,N- 
diisopropyldibenzyl phosphoramidite (0.03 cm \ 0.02 mmol) and ?mCPBA (25 mg, 0.15 
mmol). Deprotection and purification of the residue obtained was carried out as described 
for compound (16) The title compound was obtained as a white solid (41 mg, 89%); 0  ^
(D2O), 0.6-1.5 (15 H, m, octyl H), 1.91 (3 H, s, NBAc), 3.3-3.9 (12 H, m), 4.15(1 H, dd,
11.5 and 61,4.0 Hz, 6b-H), 4.22 (1 H, dd, and ^5 6^2.9 Hz, 6a-H), 4.56 (1 H, d, J, 2
8,0 Hz, l-H), 4.60 (1 H, d, J,,^,7.5 Hz, T-H); Ôc (D^O), 13.4, 22.0, 22.2, 25.0, 28.3, 28.5 
(2xC), 31.1, 55.2, 61.0, 63.2, 68.7, 70.7, 71.2 (2xC), 72.6, 75.3, 77.9, 101.2, 102.7; ôp 
(D2O), 3.5; ES-MS; Calcd for [C22H42NO14P] 574.53 obs: m/z 573.4 (M-1).
Octyl 2~acetamido-2-deoxy-4-0-(0-D-galactopyranosyl)-3,6-di-0-phosphonato-j3~D 
glucopyranoside (20).
Phosphorylation, deprotection and purification of diol (13) were carried out as 
described for compound (16) using alcohol (13) (70 mg, 0.11 mmol), l-H  tetrazole (44 mg, 
0.63 mmol), H,H-diisopropyldibenzyl phosphoramidite (0.11 cm ,^ 0.32 mmol) and wCPBA 
(70 mg, 0.42 mmol). The title compound was obtained as a white solid (65 mg, 80%); ô  ^
(D2O), 0.6-1.5 (15 H, 3xm, octyl H), 2.05 (3 H, s, NHL4c), 3.5-3.66 (2 H, m), 3.618-3.80 (3 
H, m), 3.80-4.0 (5 H, m), 4.26 (2 H, m, 6b-H, 4-H), 4.62 (2 H, dd, J 2^ and 8.3 Hz, 1- 
H, I'-H); ôc (D2O), 10.1,18.7,19.1,21.8,25.1, 25.2,27.8, 51.9, 57.6, 59.9, 65.6, 67.5, 67.9,
69.4, 70.4, 72,3, 73.1, 73.9, 86.9, 97.6, 100.1; ôp (D^O), 3.0, 4.1; ES-MS: Calcd for 
[C^AaNOnPz] 655.09 obs: m/z 327.2 (M").
Octyl 2~acetamido-3-0-(2,3,4,6-tetra-0-acetyl-j3-D-galactopyranosyl)-4,6-0-benzylidene-
2-deoxy-^D glucopyranoside (21).
Octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-p-D-glucopyranoside (8) (1.5 g, 3.6 
mmol) and bromide (3) (2.93 g, 7.1 mmol) in CHgClg (30 cm^) containing powdered 4Â 
sieves (3 g) was stirred under Nj for 3 h and cooled to -30 ” C. AgOTf (2.83 g, 11 mmol)
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was added and the suspension was stirred until t.Lc. (toluene/EtOAc, 1:1) indicated the 
reaction to be complete. Collidine (2.18 cm \ 16 mmol) was added and the solids were 
removed by filtration through Celite. The filtrate was subjected to a standard worlcup, dried 
over NagSO  ^and concentrated. The reaction mixture was dissolved in MeOH (20 cm^) and 
NaOMe (30 mg) was added. The solution was stirred at r.t. for 2 h and Amberlite IR-120 
(IT) was added until neutralisation had occurred. The mixture was filtered and the filtrate 
concentrated to dryness. Flash column chromatography (silica gel; EtOAc/EtOH/HgO 
6:2:1) gave a crunchy solid to which pyrididne (15 cm^) and AcgO (12 cm^) were added and 
the solution left to stir o/n. Azeotropic distillation with toluene followed by crystallisation 
(EtOH) yielded the title compound as a white solid (2.02 g, 75%); 0^ (CDCy 0.6-1.5 (15 
H, 3xm, octyl H), 1.89 (3 H, s, OAc), 1.91 (3 H, s, O^c), 1.93 (3 H, s, OAc), 1.98 (3 H, s, 
O^c), 2.01 (3 H, s, NHAc), 3.3-3.54 (3 H, m), 3.56-3.9 (4 H, m), 3.98 (1 H, dd, 11.2 
and J5 6a 3.5 Hz, 6a-H), 4.26 (1 H, dd, and 4.5 Hz, 6b-H), 4.65 (1 H, d, 2 8.6 Hz,
l-H), 4.66 (1 H, d, Jp,2' 8.8 Hz, I ’-H), 4.85 (1 H, dd, 3.5 and 10.1 Hz, 3’-H), 5.4-
5.56 (2 H, m), 5.22 (1 H, d, Jy ,^., 4*-H), 5.44 (1 H, s, ArCH), 5.72 (1 H, br d, /8 .4  Hz, NH), 
12-1A  (5 H, m,Ar).
Octyl 2-acetamido~6-0-acetyl-2-deoxy-3-0-(2,3,4,6-tetra-0-acetyl-/3-D-galactopyranosyl)~ 
p-D glucopyranoside (23) and octyl 2-acetamido-4-0-acetyl-2-deoxy-3-0-(2,3,4,6-tetra-O- 
acetyl-P-D-galactopyranosyl)-p-D glucopyranoside (24)
Disaccharide (21) (1 g, 1.33 mmol) was dissolved in AcOH (80%) and heated at 
80 ” C for 2 h. Azeotropic distillation with toluene followed by flash column 
chromatography (EtOAc) yielded the (22) as a white solid (600 mg, 68%) which was used 
directly in the next step.
Diol (22) (600 mg, 0.9 mmol) was dissolved in toluene (30 cm^) and 
triethylorthoacetate (1.66 cm \ 9 mmol) and /?-TsOH (catalytic) were added. The reaction 
was stirred at r.t. for 45 mins, neutralised with EtjN and diluted with CHCI3. The organic 
extract was washed with HgO, dried over NagSO  ^and concentrated to diyness. The residue 
obtained was dissolved in AcOH (80%) and heated at 40 °C for 10 mins. Azeotropic 
distillation with toluene followed by flash chromatogiaphy (toluene/EtOAc, 1:1) yielded 
acetates (23) (330 mg, 50%); §« (CDCI3) 0.6-1.5 (15 H, 3xm, octyl H), 1.97 (3 H, s, OAc),
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1.99 (3 H, s, OAc), 2.05 (3 H, s, OAc), 2.07 (3 H, s, OAc), 2.08 (3 H, s, OAc), 2.14 (3 H, s, 
NIWc). 2.96 (1 H, m, -OCH, of octyl), 3.47 (5 H, m), 3.7-4.S (11 H, m), 4.56 (1 H, d, J, ,
8.1 Hz, l-H), 4.92 (1 H, d, J,.^. 8.4 Hz, l ’-H), 5.00 (1 H, dd, 2.8 and J,.^. 9.6 Hz, 3’-H), 
5.21 (1 H, t, / r ,3. 9.6 Hz, 2 ’-H), 5.37 (1 H, d, 4’-H), 5.75 (1 H, br d, J6.6  Hz, NH). 
and (24) (170 mg, 35%); 3„ (CDCl,) 0.6-1.5 (15 H, 3xm, octyl H), 1.95 (3 H, s, 0,4c), 1.96 
(3 H, s, OAc), 1.99 (3 H, s, OAc), 2.05 (3 H, s, 0,4c), 2.06 (3 H, s, 0,4c), 2.13 (3 H, s, 
NH,4c), 3.14 (1 H, m, -OCH, of octyl), 3.4-3.9 (8 H, m), 4.27 (2 H, m), 4.57 (2 H, m), 4.85 
(1 H, t, 9.1 Hz, 4-H), 4.9-5.1 (3 H, m), 5.33 (1 H, d, 3.0 Hz, 4’-H), 5.86 (1 H, br d, J  
7.2Hz,NH).
Octyl 2-acetamido-2-deoxy-3-0-(P-D-gatactopyranosyl)-4-0-sulfonato-P-D 
glucopyranoside (25).
Sulfation of alcohol (23) was carried out as described for sulfate (11) using alcohol
(23) (76mg, 0.11 mmol), pyridine (5 cm’) and sulfur trioxide-trimethylamine (56 mg, 0.41 
mmol). Deprotection and purification of the residue obtained was carried out as described 
for sulfate (15). The title compound was obtained as a white solid (48 mg, 75%); Sj, (D^O), 
0.6-1.5 (15 H, 3xm, octyl H), 1.9 (3 H, s, NH,4c), 3.2-4.0 (12 H, m). 4.01 (1 H, dd,
12.1 and J;,a, 2.3 Hz, 6b-H), 4.1 (1 H, t, /^ O .l Hz, 3-H), 4.28 (1 H, t, 4-H), 4.45 (1 H, 
d, 8.05 Hz, l-H), 4.58 (1 H, d, 8.6 Hz, I'-H); Sc (D^O), 13.4, 22.0, 22.3, 25.1, 28.3,
28.5 (2xC), 31.1, 55.4, 60.9, 61.1, 68.9, 70.7, 72.8, 74.8, 74.9, 75.1, 78.1, 100.9, 103.7,
104.2,174.6 (C O ); FAB-MS: Calcd for [CzAiNOwS.Na] 597.61: m/z 619.7 (M+Na).
Octyl 2-acetamido-2-deoxy-3-0-(P-D-galactopyranosyl)-4-0-phosphonato-P-D 
glucopyranoside (26).
Alcohol (23) was phosphorylated as described for compound (12) using alcohol (23) 
(100 mg, 0.14 mmol), l-H  tetrazole (30 mg, 0.43 mmol), H,H-diisopropyldibenzyl 
phosphoramidite (0.07 cm’, 0.21 mmol) and mCPBA (50 mg, 0.30 mmol). Deprotection 
and purification of the oil obtained was carried out as described for compound (16) yielding 
phosphate (26) as a white solid (62 mg, 70%); 5h (D^O), 0.6-1.5 (15 H, 3xm, octyl H), 1.9 
(3 H, s, NHXc), 3.4-3.8 (12 H, m), 4.04 (2 H, m, 4-H, 6a-H), 4.5 (1 H, d, , 8.0 Hz, l-H),
4.56 (1 H, d, 7,.,j.8.6 Hz, I'-H); Sc (DjO), 13.4,22.0,22.4,25.1,28.3,28.5,28.6, 31.1, 55.3,
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60.6, 61.0, 68.6, 70.7 (2xC), 71.9, 72.5, 75.7, 80.6, 101.1, 104.2; ôp (D^O), 2.8; FAB-MS: 
Calcd for [C^zH i^NOMP-Na ]^ 619.5 obs: m/z 619.8 (M+1).
Octyl 2-acetamido-2-deoxy-3-0-(P-D-galactopyranosyl)-6-0-sulfonato~j3-D 
glucopyranoside (27).
Sulfation of alcohol (24) was carried out as described for sulfate (11) using alcohol
(24) (130 mg, 0.18mmol), pyridine (10 cm^) and sulfur trioxide-trimethylamine complex 
(75 mg, 0.53 mmol). Deprotection and purification were carried out as described for sulfate 
(15) yielding sulfate (27) as a white solid (96 mg, 88%); ô^ (DjO), 0.6-1.5 (15 H, 3xm, 
octyl H), 1.9 (3 H, s, NIMc), 3.3-3.8 (12 H, m), 4.23 (1 H, dd, 11.0 and 5.4 Hz, 
6a-H), 4.38 (1 H, dd, and Jg,gy 1.74 Hz, 6b-H), 4.45 (1 H, d, 8.1 Hz, l-H), 4.59 (1 
H, d, 8.1 Hz, r-H); ôc (D^O), 13.4, 22.0, 22.3, 25.0, 28.3, 28.5 (2xC), 31.1, 54.6, 61.1, 
67.2, 68 .6, 70.7 (2x0), 72.5, 73.3, 75.3, 82.2, 101.0, 103.6; ES-MS: Calcd for 
[C22H4iNO,4S] 574.6 obs: m/z 574.0 (M-1).
Octyl 2-acetamido-2~deoxy-3-0-(P-D-galactopyranosyl)-6~0-phosphonato-/3-D 
glucopyranoside (28).
Alcohol (24) was phosphorylated as described for compound (12) using alcohol (23) 
(100 mg, 0.14 mmol), l-H  tetrazole (30 mg, 0.43 mmol), HH-diisopropyldibenzyl 
phosphoramidite (0.07 cm \ 0.21 mmol) and mCPBA (50 mg, 0.30 mmol). Deprotection 
and purification of the oil obtained was carried out as described for compound (16) yielding 
phosphate (26) as a white solid (88 mg, 99%); ô^ (D^O), 0.6-1.5 (15 H, 3xm, octyl H), 1.90 
(3 H, s, m U c), 3.3-3.95 (12 H, m), 4.01-4.11 (1 H, m, 6a-H), 4.19 (1 H, dd, 11.1 and 
Vg,gy 5.21 Hz, 6b-H), 4.46 (1 H, d, 8.1 Hz, l-H), 4.58 (1 H, d, 7,.2- 8.1 Hz, I’-H); Ôc 
(DjO), 13.4,22.0,22.2,25.0, 28.3, 28.5, 31.1, 54.7, 61.1, 64.0, 68.4, 68.6, 70.7 (2xC), 72.6, 
74.4 (2xC), 75.3, 82.0, 101.0; ôp (DgO), 5.3; ES-MS: Calcd for [C22H42NOMP] 574.53 obs: 
m/z 572.9 (M-1).
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Octyl 2-acetamido-2-deoxy-3-0-(P-D~galactopyranosyl)-4, ô-di-O-sulfonato-fi-D 
glucopyranoside (29).
Sulfation of diol (22) was carried out as described for sulfate (11) using alcohol 
(22) (55 mg, 0.08 mmol), pyridine (3 cm^) and sulfur trioxide-trimethylamine complex (90 
mg, 0.66 mmol). Deprotection and purification were carried out as described for sulfate 
(15) yielding di-O-sulfate (29) as a white solid (49 mg, 88%); Ôh (D jO), 0.6-1.5 (15 H, 
3xm, octyl H), 2.05 (3 H, s, NHzlc), 3.54 (1 H, m, -OCH^ octyl), 3.6-3.S (5 H, m), 3.8-4.0 
(5 H, m), 4.1-4.2 (2 H, m, 6a-H, 6b-H), 4.26 (1 H, t, Jy, 8.7 Hz, 4-H), 4.5 (1 H, d,  ^7.5 
Hz, l-H), 4.6 (1 H, d, Jp,2.8.1 Hz, T-H); Ôc (D^O) 10.1, 18.7, 19.1, 21.8, 25.0, 25.2 (2xC), 
27.8, 51,9, 57.8, 64.5, 65,7, 67,4, 67.5, 69.5, 69.6, 71.6, 71.9, 74.7, 97.5, 100.4, 171.3 
(C=0); ES-MS: Calcd for [C22H41NO17S2] 654.66 obs: m/z 327.9 (M" ).
Octyl 2-acetamido-2~deoxy-3-0-(l3-D-galactopyranosyl)-4,6-di-0-phosphonato-p~D 
glucopyranoside (30).
Diol (22) was phosphorylated as described for compound (12) using alcohol (22) 
(55 mg, 0.08 mmol), l-H  tetrazole (30 mg, 0.43 mmol), H,/V-diisopropyldibenzyl 
phosphoramidite (0.08 cm \ 0.24 mmol) and mCPBA (57 mg, 0.33 mmol). Deprotection 
and purification of the oil obtained was carried out as described for compound (16) yielding 
phosphate (30) as a white solid (58 mg, 99%); ô^ (D2O), 0.6-1.5 (15 H, 3xm, octyl H), 2.04 
(3 H, s, NHAc), 3.5-3.8 (5 H, m), 3.8-4.0 (5 H, m), 4.06 (2 H, m, 6a-H, 6b-H), 4.16 (I H, 
dd,J4,5and /3,49.3 Hz, 4-H), 4.51 (1 H, d , / 127.0 Hz, l-H), 4.59 (1 H, d,/p,2'8 7 Hz, I ’-H); 
ôc (DgO) 10.1, 18.7, 19.1, 21 .8, 25.1, 25.2 (2xC), 27.8, 51.8, 57.7, 60.6, 65.4, 67.3, 67.5,
68.7, 69.3, 71.2, 72.2, 76.7, 97.8, 100.2, 171.3 (C=0); ôp (D^O) 3.7, 6.1; ES-MS: Calcd for 
[C22H43NO17P2] 655.49 obs: m/z 327.6 (M"“).
Octyl 2~acetamido-2-deoxy-4-0-( p-D-galactopyranosyl)-(3-D glucopyranoside (31).
A solution of compound (13) (100 mg, 0.15 mmol) in MeOH (10 cm^) containing 
NaOMe (10 mg) was stirred at r.t. for 4 h. Amberlite IR-120 (H^) resin was added and the 
mixture was stirred until neutralisation had occurred. The suspension was filtered and the 
filtrate was concentrated to dryness to give the title compound as a crunchy solid (70 mg, 
94%); ÔH (D2O), 0.6-1.5 (15 H, 3xm, octyl H), 2.05 (3 H, s, NHu4c), 3.5-3.95 (10 H, m),
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4.01 (1 H, br d, 11.6 Hz, 6b-H); ôc (D^O), 13.2, 21.6, 25.7, 29.1, 29.2 (2xC), 31.6, 55.4,
60.6, 61.1, 69.0, 69.3, 71.3, 72.9, 73.5, 75.2, 75.8, 79.7, 101.5, 103.8; FAB-MS: Calcd for 
[C22H42N0„] 495.55 obs: m/z 496 (M+1), 517.9 (M+Na).
Octyl 2-acetamido-2-deoxy-3-0-(P-D-galactopyranosyl)-P-D glucopyranoside (32).
A solution of compound (22) (105 mg, 0.15 mmol) in MeOH (10 cm^) containing 
NaOMe (10 mg) was stirred at r.t. for 4 h. Amberlite IR-120 (H"^ ) resin was added and the 
mixture was stirred until neutralisation had occurred. The suspension was filtered and the 
filtrate was concentrated to diyness to give the title compound as a crunchy solid (76 mg, 
96%); Ôh (D2O), 0.6-1.5 (15 H, 3xm, octyl H), 2.04 (3 H, s, NFMc), 3.4-3.7 (5 H, m), 3.7- 
3.85 (5 H, m), 3.92 (2 H, m, 6a-H, 6b-H), 4.44 (1 H, d, /;^7.6 Hz, l-H), 4.57 (1 H, d, /py
7.6 Hz, r-H); ôc (DgO), 11.5, 20.1, 20.4, 23.2, 26.4, 26.6, 29.2, 52.7, 58.8, 59.1, 66.6, 66.8,
68.7, 68.8, 70.6, 73.4, 73.5, 80.6, 99.0, 101.6, 172.6 (C=0); FAB-MS: Calcd for 
[C22H42NO1,] 495.55 obs: m/z 496 (M+1), 517.9 (M+Na).
Octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-3-0-methanesulfonyl-/3-D-glucopyranoside
(33)
Compound (33) was prepared by sulfonylation of compound (8) using a procedure 
described by Vasella and co-workers [6], To a solution of octyl 2-acetamido-4,6-0- 
benzylidene-2-deoxy-p-D-glucopyranoside (8) (1.44 g, 3.42 mmol) and Et^N (0.72 cm\ 
5.13 mmol) in CH2CI2 (10 cm^) was added a solution of methanesulfonyl chloride (0.44 
cm\ 5.7 mmol) in CH2CI2 (5 cm^). Once t.l.c. (toluene-EtOAc, 4:1) showed the reaction to 
be complete (1 h) CH2CI2 was added and the solution was washed with HjO (3x20 cm )^ 
dilute NaOH solution (20 cm^) and HjO (20 cm^). The organic layer was dried over Na2S04 
and concentiated to dryness. Crystallisation yielded white needles of the title compound 
(1.46 g, 85%); m.p. 172-174 "C (CH2CI2 / hexane); [a]o -35.8 (c 0.1, CHCI3); (Found, C, 
57.47; H, 7.53; N, 2.78. C24H32O8NS requires C, 57.69; H, 7.46; N, 2.80); 0» (CDCI3), 0.6-
1.5 (15 H, 3xm, octyl H), 2.03 (3 H, s, NHXc), 2.93 (3 H, s, -SO^m), 3.3-3.9 (6 H, m), 4.40 
(1 H, d d , 9.3 and/gg. 10.4 Hz, 6 ’-H), 5.15 (1 H, d, /,,2 8-1 Hz, l-H), 5.26 (1 H, dd,
9.3 and Jy, 9.5 Hz, 3-H), 5.54 (1 H, s, ArCH), 5.86 (1 H, d, J  1.1 Hz, NH), 7.52 (5 H, m, 
Ar).
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Octyl 2-acetamido-4,6-0-benzylidene-2-deo^-j3-D-allopyranoside (34)
Displacement of the 3-O-methanesulfonyl group of (33) to give the a//o-configured 
alcohol was carried out using a procedure used by Vasella and co-workers [6], A solution of
(33) (53 mg, 1.00 mmol), 2-methoxyethanol (6 cm^), NaOAc (41 mg, 5.00 mmol) and HjO 
(0.3 cm^) was refluxed at 115 ° C under argon. After 20 h t.l.c. (toluene/EtOAc, 2:1) showed 
the reaction to be complete. CH2CI2 was added and the solution was washed with HgO (2x15 
cm^), dried over NagSO ,^ and concentrated to dryness until almost all the CHjClj had 
evaporated. Hexane was added and white needles of the title compound formed (45 mg, 
98%); m.p. 186-188 "C; [aj^ -65 (c 0.1, CHCI3); (Found C, 65.59; H, 8.45; N, 3.29. 
C23H3gOgN requires C, 65.53; H, 8.37; N, 3.33); Ôh (CDCI3), 0.6-1.5 (15 H, 3xm, octyl H),
2.02 (3 H, s, NH^c), 3.42 (1 H, m, -OCH% octyl chain ), 3.6-4.0 (4 H, m), 4.14 (1 H, m, 5- 
H), 4.25 (l-H, br s, 3-H), 4.35 (1 H, dd, 3.0 and J4.5 6.0 Hz, 4-H), 4.63 (1 H, d, J ,.2 8.4 
Hz, l-H), 5.59 (1 H, s, ArCH), 5.96 (1 H, br d, J 8.6 Hz, NH), 7.2-7.4 (5 H, m, Ar).
Octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-3-0-methanesulfonyl-p-D-allopyranoside 
(35)
Compound (35) was prepared using the procedure described for compound (33) 
above. To a solution of octyl 2-acetamido-4,6-(9-benzylidene-2-deoxy-p-D-allopyranoside
(34) (100 mg, 0.24 mmol) and Et3N (0.05 cm \ 0.35 mmol) in CHgClg (5 cm^) was added a 
solution of methanesulfonyl chloride (0.03 cm ,^ 0.35 mmol) in CHgClg (2 cm^). Once t.l.c. 
(toluene/EtOAc, 4:1) showed the reaction to be complete (10 min), CHgClg was added and 
the solution was washed with HgO (3x20 cm^), dilute NaOH solution (20 cm^) and HgO (20 
cm )^. The organic layer was dried over NagSO  ^and concentrated to dryness. Crystallisation 
yielded white needles of the title compound (85 mg, 72%); m.p. 166-168 °C (CHgClg / 
hexane); [aj^ -29.6 (c 0.05, CHCI3); (Found, C, 57.56; H, 7.45; N, 2.86. C24H37O8S requires 
C, 57.69; H, 7.46; N, 2.80); Ôh (CDCI3), 0.6-1.5 (15 H, 3xm, octyl H), 2.04 (3 H, s, NHXc), 
2.98 (3 H, s, -SOjMe), 3.46 (1 H, dt, J2.6  and 6.7 Hz, -OCH^ octyl chain), 3.74-3.94 (3 H, 
m), 4.28 (1 H, dt,  ^2.8 and 8.7 Hz, 2-H), 4.41 (1 H, dd, 4.2 and /g.g. 9.6 Hz, 6’-H), 
4.67 (1 H, d, /p2, 1 -^ , 5.27 (1 H, dd, J2.3 and 73.4 2.6 Hz, 3-H), 5.58 (1 H, s, ArCH), 5.73 (1 
H, d, 78.4 Hz, NH), 7.36 (5 H, m, ArH).
Octyl 2-acetamido-3-azido-4,6-0-benzylidene-2,3-dUdeoxy-P-D-glucopyranoside (36)
Compound (36) was prepared using a procedure described by Wong and co-workers
[7], A suspension of octyl 2-acetamido-4,6-0-benzylidene-2-deoxy-3-0-methanesulfonyl- 
p-D-allopyranoside (35) (80 mg, 0.2 mmol) and NaNg (130 mg, 2 mmol) in DMF (2 cm^) 
was stirred at 110"C for 4 h. The solution was cooled to r.t. and CHCI3 was added. The 
mixture was washed with HjO (2x10 cm^) and NaCl (10 cm^). The organic layer was dried 
over Na^SO ,^ concentrated to dryness, and separated by flash chromatography 
(toluene/EtOAc, 1:1). Crystallisation gave white needles of the title compound (60 mg, 
65%); m.p. 226-229 “C (EtOH); [a]o 23.0 (c 0,47, CHCI3); (Found C, 61.99; H, 7.83; N, 
12.25. C23H35O5N4 requires C, 61.86; H, 7.67; N, 12.55); 3260 (NH), 2105 (N3), 1560
(CO); ÔH (CDCI3) 0.6-1.5 (15 H, 3xm, octyl H), 2.04 (3 H, s, NHWc), 3.20 (1 H, m, -OCH, 
octyl chain), 3.4-3.6 (3 H, m), 3.7-3.9 (2 H, m), 4.36 (1 H, dd, /jg. 4.3 and Tgg. 10.3 Hz, 6'- 
H), 4.50 (1 H, t, 72,3 and 73.4 10.5 Hz, 3-H), 5.04 (1 H, d, 7;,2 8.1 Hz, l-H), 5.57 (1 H, s, 
ArCH), 1.3-1 A  (5 H, m, ArH).
Octyl 2-acetamido-3-azido-6-0-benzyl-2,3-di-deoxy-J3-D-glucopyranoside (37)
Compound (37) was prepared using a selective acetal ring opening procedure 
described by DeNinno and co-workers [5]. To an ice-cold suspension of octyl 2-acetamido-
3-0-azido-4,6-0-benzylidene-2-deoxy-p-D-glucopyranoside (36) (50 mg, 0.11 mmol) and 
tiiethylsilane (0.09 cm \ 0.55 mmol) in CHgClg (2 cm^), TFA (0.04 cm\ 0.55 mmol) was 
added dropwise. The solution was allowed to warm to r.t. Once t.l.c. (toluene/EtOAc, 1:1) 
showed the reaction to be complete (4 h), EtOAc was added and the solution was subjected 
to a standard work up. The product was purified by flash chromatography (toluene/EtOAc, 
2:1) to afford the alcohol (37) as white needles (47 mg, 93%); m.p. 110-112 " C; [aj^ -16 (c
0.47, CHCI3); (Found C, 61.65; H, 8.38; N, 12.62. C23H3gO$N requires C, 61.59; H, 8.09; N, 
12.49.); 3265 (NH), 2110 (N3), 1655 (CO); 6» (CDCI3), 0.6-1.5 (15 H, 3xm, octyl H),
1.94 (3 H, s, m iAc), 2.98 (1 H, m, -OCHg octyl chain), 3.30-3.55 (3 H, m), 3.60-3.80 (3 H, 
m), 4.13 (1 H, dd, u^^and f^ ,9 .1  Hz, 3-H), 4.51 (2 H, dd, 12.0 Hz, ArCHj), 4.86 (1 H, d,
7 i,2 8.0 Hz, l-H), 5.64 (1 H, d, 76.6 Hz, NH), 7.24 (5 H, m, ArH).
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Since the discovery that carbohydrates are involved in many processes in biological 
systems, there has been an increased interest in the preparation of naturally occurring 
oligosaccharides. New techniques and methods of analysis have simplified the task of the 
organic chemist in synthesis of such complex oligosaccharides. However, chemical 
synthesis of oligosaccharides involves many protecting group manipulations, and coupling 
reactions are typically low yielding. To malce a single monosaccharide building block talces 
an average of five synthetic steps (at approximately one step per week). Therefore the task 
of preparing complex oligosaccharides synthetically is both time consuming and expensive. 
The chemo-enzymatic synthesis of carbohydiate molecules has therefore many advantages. 
The specificity and catalytic power of enzymes can be exploited to carry out regio- and 
stereo-controlled coupling reactions on unprotected or partially protected compounds. This 
reduces the number of chemical steps necessary in the synthesis of oligosaccharides. The 
disadvantage is in the range of substrates specific enzymes can tolerate and in some cases 
(for example, the synthesis of sulfate and phosphate derivatives of octyl LacNAc) a 
chemical method is the only suitable method to synthesise unnatural molecules.
There are several different methods for creating glycosidic linlcages enzymatically. 
The enzymes typically used are glycosidases, phosphorylases and glycosyltransferases [1]. 
The donor molecules fi-equently employed for glycosidases are firee sugars, gl>jcosides, 
phenyl glycoside derivatives and glycosyl fluorides. Phosphorylases use sugar-1- 
phosphates as donors and glycosyltransferases require the naturally occurring sugar 
nucleotide donors. Studies have been carried out to determine the acceptor specificities for 
many glycosyl transferase enzymes and it has been found that for some enzymes there are 
key hydroxyl groups involved in recognition and binding to the enzyme [2] - [3]. Only these 
key polar gi*oups cannot be altered without adversely effecting the binding and rate of 
reaction. Substitutions at other sites of the acceptor sugar can be tolerated, enabling the 
enzymatic synthesis of unnatural oligosaccharides.
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5.1.1 Chemo-Enzymadc Synthesis off Octyl LacNAc
The enzymatic synthesis of octyl LacNAc uses octyl GlcNAc (7) as an acceptor 
which was prepared chemically in three steps as discussed in Chapter 3. The method 
chosen for the enzymatic glycosidation using bovine p-l,4-GalT (EC 2.4.1.22) was a 
variation of a method described by Wong and co-workers [4], [5] and Flitsch and co­
workers [6]. The expensive donor in the reaction, UDP-Gal, was generated in situ using 
UDP-Glc and UDP-Glc-4-epimerase. A problem encountered was the poor solubility of the 
acceptor substrate in the assay buffer. Despite sonication, heating and addition of 10% v/v 
DMSO, the acceptor remained a gel in the assay mixture. However, galactosylation of octyl 
GlcNAc was achieved in 56% yield in 24 h. Analytical data was identical to that obtained 
for synthetically prepared (31).
Synthesis of octyl LacNAc using a chemo-enzymatic method was overall less time 
consuming, less expensive and higher yielding than the corresponding chemical method 
involving eleven steps (overall yield from octyl GlcNAc 22%).
5.1.2 Synthesis off a°2,3-S:alyi Octyl LacNAc Analogues
The synthesis of the sialylated derivatives 36-39 (Figure 5-1) was carried out using 
a glycosidase enzyme, rraw^-sialidase (from Trypanosoma cruzi) [7]. The donor used in the 
reaction was the p-nitrophenyl glycoside of sialic acid (PNP-NeuAc ) which was available 
in our laboratories.
,0HHO NHAc
•O2C 0-octyl
OH OH OH
HO-
AcHN OH Y = OH36. X = OH
Y = 0 S 0 3 ‘ 
Y = 0 P03  ^
39. X = OSO3" Y = OH
37. X s  OH
38. X = OH
Figure 5-1: Sialylated Octyl LacNAc Substrates
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Attempts were also made to sialylate the 6-O-phosphate (19), 3,6-di-O-sulfate (18) 
and 3,6-di-O-phosphate (20) derivatives of octyl LacNAc but no turnover was observed by 
t.l.c. This was thought to be due to the highly charged nature of the substrates, perhaps 
causing tight solvation of the molecules and interfering with binding to the enzyme. 
Experiments are currently being carried out to investigate this possibility.
Purification of the compounds (36)“>(39) (Figure 5-1) was carried out by passage 
through QAE-Sephadex AG-25 as described in Chapter 3. However, a side product from 
the assay was p-nitrophenol which eluted with the sialylated compounds from the SepPalc 
cartridges. Removal of p-nitrophenol was achieved by column chromatography using a size 
exclusion lipophilic Sephadex LH-20 resin using methanol as the mobile phase.
5.1.3 Chemo-Emzymatlc Synthesis off Octyl Lewis x
Octyl Lewis x (41) was prepared according to Scheme 5-1. This order of events was 
chosen over direct fucosylation of octyl LacNAc due to the higher turnover observed when 
sialyl octyl LacNAc was used as a substrate with a-l,3-FucT. The synthesis makes use of 
readily available human milk Lewis a-l,3-FucT (kindly provided by M. M. Palcic) and 
commercially available neuraminidase type V (from Clostridium perfringens).
p HHO NHAc
HO 0-octyl
HO
QH OH
HO (36)
AcHN OH
OH
OH
OH
OH
OH (40)
OHAcNH Neuraminidase type V 
{Clostridium perfringens)HO
OH
OH
HO
OH
OH
Scheme 5-1; Synthesis of Octyl Lewis x
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To gain information regarding the substrate specificity of a-l,3-FucTs the 
compounds shown in Figure 5-1, Figure 5=2 and Figure 5-3 were to be used as substrates 
to screen for activity with semi-pure a-l,3/4-FucT (human milk) and five recombinant a- 
1,3-FucT’s (III-VII, gratefully received as a gift from Dr. C. Britten, Glaxo Wellcome).
HO NHAc
0 -octyl
——— — " '31. K = OH Y = OH
15. X = OH Y = OSOa"
16. X = OH Y = OPOa^’
17. X = O SO 3 ’ Y ~ O H
19. X = OPOa^' Y = OH
18. x = 0 S 0 a' Y = O SO s'
20. X = oP O a^' Y = OPOa^'
Figure 5-2: Octyl LacNAc Substrates
-----------------------------^
32. X = OH Y =O H
HO OH 25. X =OH Y = OSOa’
I \  0 (  „ 26. X = OH Y = OPOa^’
H O -J 0 -octyl 27. X = OSOa' Y = OH
OH NHAc 28. X = OPOa^" Y= OH
29. X = OSOa’ Y = OSO3’
30. X = OPOa^’ Y = OPOa^’
Figure 5-3: Octyl Gal-p-ljS-GlcNAc Substrates
These compounds all contain an octyl chain which allows the product from the enzymatic 
reaction to be separated from starting materials and enzyme by reverse phase 
chromatography using C,g SepPak cartridges [8]. In order to detect product formation, a 
radiochemical assay system described by Palcic and co-workers [8] was chosen. The 
radiochemical donor used was GDP-[^H]-fticose. The kinetic experiments were carried out 
at 37 "C, quenched with water and loaded onto a SepPalc cartridges. Only compounds 
containing a hydrophobic residue adhered to the cartridges. All other substances present in 
the assay mixture were washed from the SepPalc with water. Any radiolabelled product
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formed during the assay was then eluted from the caitridge with MeOH, diluted with 
scintillation coclctail and counted in a scintillation counter. The Michaelis-Menten equation 
was then applied to determine and values using a Lineweaver-Bui’k plot. However 
Michaelis-Menten kinetics applies to reactions involving a single substrate. For a-l,3-FucT 
reactions two substrates are required, the acceptor substrate and the donor, GDP-Fuc. To 
overcome this problem, donor concentrations were used at saturation level and can thus be 
regarded as constant.
The studies reported in this chapter malce use of a number of recombinant 
fucosyltransferases. Due to the poor availability of the corresponding native enzymes it is 
not possible to do detailed Icinetic comparisons between two forms of the same enzyme. It 
is therefore inappropriate to quantitatively compare turnover data (F^ax) for different 
substrates with different recombinant enzymes and draw ‘physiologically relevant’ 
conclusions. The data reported are therefore interpreted in a conservative fashion, with 
relative Vmax/K values quoted rather than values.
Table 5-1 to Table 5-6 give the results obtained when the compounds shown in 
Figure 5-1 to Figure 5-3 were screened against all of the a-l,3-FucT’s.
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5.2.1 Lewis a-l,3/4-FucT (human milk)
Substrate
(pM)
Fmax
(pitiol/min/pl)
Rel.
Type I
Gal-p-l,3-GlcNAc-OR (32)' 2560 30.0 85
4-0-sulfate (25) 16900 1.15 0.5
4-O-phosphate (26) 18800 0.53 0.2
Type II 
Gal-P-l,4-GlcNAc-OR (31) 350 4.92 100
3-O-sulfate (15) 3120 5.07 11
3-0-phosphate (16) 2470 0.30 0.9
Table 5-1: Kinetic Data for Lewis a-l,3/4-FucT
The 6-0-sulfate and 6-O-phosphate compounds were not tested as substrates for this
enzyme.
R = (octyl) in this and all subsequent tables.
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5.2.2 a -l^ -F n cT m
Substrate
( |iM )
V^ max(pmol/min/mg)
Type I
Gal-P-l,3-GlcNAc-OR (32) 1700 42640 100
6-0-sulfate (27) 600 6980 46
6-O-phosphate (20) 300 10850 144
Type II
Gal-p-I,4-GlcNAc-OR (31) >7000 - -
6-0-sulfate (17) 1500 780 2
6-O-phosphate (19) 500 1320 11
Sialylated Type II
Gal-p-l,4-GlcNAc-0R (36) >1000 " -
3-O-sulfate (37) >1000 - -
6-0-sulfate (39) 7600 930 1
3-0-phosphate (38) >1000 - -
Table 5-2: Kinetic Data for a-l,3-FucT IIÎ
Accurate kinetic data were not obtained for the substrate Gal-p-1,4-GlcNAc-OR due 
to problems of insolubility. The maximum solubility of this substrate is 2mM which is 
much lower than the value. values were not determined for substrates with K, 
>10mM.
M
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5.2.3 a-l,3-FucTW
Substrate
(pM)
V^ max(pmol/min/mg)
Rel.
Type II
Gal-p-l,4-GlcNAc-OR (31) 1400 39 100
6-0-sulfate (17) 1400 79 202
6-O-phosphate (19) 500 16 115
Table 5-3: Kîmeüc Data for a-l,3-FucT IV
Compounds with substitutions at the 3-position of octyl LacNAc and sialylated 
derivatives were found to be non-substrates for a-l,3-FucT IV. Type I compounds were not 
tested as substrates for this enzyme.
5.2.4 a-l^-FucT V
Substrate
(pM)
V^ max(pmol/min/mg)
Ret. V„fgJK^
Type II
Gal-p-l,4-GlcNAc-0R (31) >5000 - -
6-O-sulfate (17) 9000 840 84
6-O-phosphate (19) 2300 95 37
Sialylated Type II
Gal-p-l,4-GlcNAc-OR (36) 4400 490 100
3-O-sulfate (37) 1300 10 7
6-O-sulfate (39) 3000 360 108
Table 5-4: îCImetic Data for a-1.3-FucT
Compounds with substitutions at the 3-position of octyl LacNAc were found to be 
non-substrates for a-l,3-FucT V. An exception was the sialylated 3-O-sulfate compound 
which had a smaller than that of the parent compound, sialylated octyl LacNAc. The
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kinetic parameters for sialylated octyl LacNAc containing a phosphate at the 3-position 
could not be determined. When assays were carried out, a scatter of counts were observed 
with no con-elation between duplicate experiments. A reason for this could be due to the 
large number of charges on the molecule. This would affect the affinity of the compound 
with the C,8 SepPak cartridges. In an attempt to overcome this problem, the SepPaks were 
treated with acid (distilled water acidified with TFA to a pH of 1.4) prior to the compound 
being loaded on. This method proved successful with highly charged substrates with a-1,3- 
FucT VI (5.2.5). However, for a-l,3-FucT V, no accurate data was obtained. Type I 
compounds were not tested as substrates for this enzyme.
5.2.5 a-l,3-FucTVI
Substrate
(pM)
F^ max(pmol/min/mg)
Type II
Gal-P-l,4-GlcNAc-0R (31) 115 2510 100
3-O-sulfate (15) 495 5015 46
3-0-phosphate (16) 785 1180 7
6-O-sulfate (17) 0.85 3940 21260
6-O-phosphate (19) 4.95 2420 2245
3,6-di-O-sulfate (18) 390 945 11
3,6-di-O-phosphate (20) 545 910 8
Sialylated Type II
Gal-P-l,4-GlcNAc-OR (36) 10 1205 555
3-O-sulfate (37) 160 1035 30
3-O-phosphate (38) 420 535 6
6-O-sulfate (39) 4.4 1100 1150
Table 5-5: Kinetic Data for a-ljS-FucT VI
All of the compounds assayed with a-l,3-FucT VI proved to be good substrates for 
the enzyme. In particular compounds with substitutions at the 6-position proved to be
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excellent substrates with values much lower (xlOOO) than the parent compound. The 
compounds with a sulfate or phosphate gi'oup at both the 3 and 6-positions have kinetic 
parameters similar to those of the 3-O-sulfate and phosphate derivatives. For the sialylated 
compounds, the 6-O-sulfate was also a good substrate, with Idnetic parameters similar to 
those of the sialyl octyl LacNAc. Type I compounds were not tested as substrates for this 
enzyme.
5.2.6 a-lJ-F ucT V n
Substrate -^ M
(pM)
V^ max(pmol/min/mg)
Type II
Gal-p-l,4-GlcNAc-OR (31) 110 19.9 100
Sialylated Type II
Gal-p-l,4-GlcNAc-OR (36) 1320 33.1 14
3-O-sulfate (37) 820 86.1 58
6-O-sulfate (39) 280 450.3 888
Table 5-6: ïCinetk Data for a-l^ F u cT  VÏÏ
An interesting point was the observation that octyl LacNAc was an apparent 
substrate for a-l,3-FucT VII. This is contrary to previous reports [9], which suggested that 
a-l,3-FucT VII would only tolerate substrates containing an a-2,3-sialic acid moiety. 
Assays were carried out for the octyl LacNAc compounds containing sulfate and phosphate 
substitutions. Sulfate and phosphate substitutions at the 3-position rendered the compound 
inactive with a-l,3-FucT VII. Sulfate and phosphate substitutions at the 6-position 
appeared to be substrates for the enzyme (comparing directly all the compounds with a-1,3- 
FucT VII at ImM concentrations, for 0.5 h incubations), however on carrying out 
determining experiments, no coherent results were obtained and no consensus between 
duplicate experiments was observed. This result can not yet be explained. Type I 
compounds were not evaluated as substrates for this enzyme.
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5.2.7 Conclusion
It can be seen from the results shown in Table 5-1 - Table 5-6 that the presence of 
an anionic functionality in the substrate molecules profoundly affects the and 
values for any given en2yme. In particular the presence of a sulfate group at position 6 of a 
substrate generally improves the value relative to the parent compound. An interesting 
observation is that for a-l,3-FucT VI the 3-O-sulfate (IS) and 3-O-phosphate (16) 
derivatives are good substrates for the enzyme with and values in a similar range to 
those of the parent compound. This is in agreement with the results obtained by Palcic and 
co-workers (unpublished results) for the human milk a-l,3/4-FucT using LacNAc-MCO^ 3- 
0-sulfate as a substrate. This is unexpected as the sulfate or phosphate moieties are at the 
site of glycosylation. An explanation could be that the fucose is transferring to the oxygen 
of the sulfate or phosphate groups to form sulfate and phosphate diester linlcages as shown 
in Figure 5-4.
HO OH
OH
,0HHO NHAc
0 -octylHO
OH
OH
Figure 5-4: Pbosplute Diester Linkage
5.2.7.1 Verification o f  Phosphate Diester Linkage
A sulfate diester linkage would be expected to be unstable, however, glycosyl 
phosphate diester linlcages are Icnown in nature and so should be stable to isolation [10]. 
Therefore studies were concentrated on identifying the product of the reaction of octyl 
LacNAc 3-O-phosphate (16) with a -1,3-fucosyltransferase. The enzyme chosen to study 
this was the Lewis a-l,3/4-FucT (human milk) as it was a highly concentrated enzyme and
 ^MCO= 8 -methoxycarbonyloct-l-yl
103
has previously been shown to be usefiil in large scale biotransformation reactions (5.1). To 
monitor the reaction MALDI-TOF was chosen. Using this technique, the enzymatic mixture 
could be directly measured without prior purification steps.
HO OH
OH
^ Calcd m/z: 720.53 
Obsm/z: 719.9,0 HHO NHAc
0-octylHO-
OH
OH
HO OH
OH Calcd m/z: 624.5 
Obs m/z: 626.2 (M+1)OHHO NHAc
0-octylHO.
OH
OH(41)
Figure 5-5: Results of Attempted Characterisation of the Phosphate Diester
The preliminary results of this assay did show the presence of a species of molecular weight 
corresponding to a fiicosylated, phosphorylated octyl LacNAc derivative (Figure 5-5). It 
was also observed that there was a compound present with a molecular ion of 626.2. This 
corresponds to the trisaccharide octyl Lewis x (41). If the phosphate monoester was being 
cleaved octyl LacNAc would be formed which would be fiicosylated to give octyl Lewis x. 
It was thought that the alkaline phosphatase present in the assay to degrade the GDP side 
product, could be responsible for the cleavage of the phosphate linkage. A second assay 
was set up containing no alkaline phosphatase. MALDI-TOF showed again the presence of 
a species which corresponded to a fiicosylated, phosphorylated octyl LacNAc derivative. 
However, despite numerous attempts it was not possible to obtain sufficient material to 
isolate and characterize. A reason for this could be due to the build up of GDP which is an 
inhibitor of the enzyme.
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A second strategy was adopted to verify the presence of the phosphate diester 
product. A radiochemical assay was set up using a-l,3-FucT VI and octyl LacNAc 6-O- 
phosphate (19). The product from this assay was loaded onto a t.lc. plate. The t.l.c. was 
developed (CHClj/MeOH/HjO, 10:10:3) and the silica gel was removed from the plate in 1 
cm strips. Methanol was added and the suspensions were voitexed thoroughly, centrifuged 
and the supernatant removed. This process was repeated twice and the combined 
supernatants were counted. Figure 5-6 shows the results obtained.
phosphate 
diester maricer
350 
300 
250 
200 
150 
100 
SO .
octyl
marker
\ /
I counts par minute
0-1 cm 1-2cm 2-3crn 3-4cm 4-Ocm S-Ocm 6-7em
Figure 5-6: Churt Showing the Silica Gel Bands Containing Radioactive Counts
The sections 2-3 cm and 3-4 cm contained the highest number of radioactive counts (~ 
quantitative recovery of total number of counts loaded onto t.l.c. plate). This corresponded 
exactly with the Rf of the authentic phosphate diester product (synthesised from phosphate
(16) by Taketo Uchiyama in the laboratories of Prof. O. Hindsgaul, University of Alberta). 
The section corresponding to that of octyl Lewis x (section 4-5cm) contained only 
background levels of radioactivity. These results lend support to the notion that the 
phosphate group is being glycosylated in the fucosylation reaction with a-l,3/4-FucT VI.
5.2.8 Bovine p-lg&GulT Kinetics
The compounds shown in Figure 5-7 were synthesised as a model study to 
investigate the most suitable method for carrying out sulfation and phosphorylation 
reactions. GlcNAc derivatives are substrates for (bovine) D-glucose p-l,4-GalT (EC
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2.4.1.22) and so the sulfate and phosphate derivatives of octyl GlcNAc were evaluated as 
substrates for p-l,4~GalT. The was found to be 150pM for octyl GlcNAc. Accurate 
kinetic data was not obatined for this substrate due to problems of insolubility. Compounds 
containing a sulfate or phosphate moiety were non-substrates for the enzyme. This data
agrees with previously reported results that substitutions at the 4-OH of GlcNAc are not 
tolerated by P-l,4-GalT [2].
.OH .OH.OH
0— 8—0HO O—P— OO-octyl 0-octylO-octylHO HOHO
AcHN AcHN
(11)
AcHN
(12)
Figure 5-7; Octyl GlcNAc Substrates for p-l;4-GmiT (bovine)
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a-l,3/4-FucT used was semi-pure enzyme isolated from human milk by Prof. M. 
Palcic and co-workers at the University of Alberta. Recombinant a-l,3-FucT’s were a gift 
from Dr. C. Britten at GlaxoWellcome. a-l,3-FucT III, IV and V were expressed by 
transient transfection in COS-1 cells. a-l,3-FucT VI and VII were expressed by infection of 
Trichoplusia ni by recombinant baculovirus. Tr^wj-sialidase used was recombinant enzyme 
expressed in E. Colt by Jennifer Harrison in our laboratories. A standard preparation of this 
enzyme involved cells from a 10 L culture sonicated in 500 cm  ^of phosphate buffer, pH 8 
containing 300 mM NaCl. The mixture was spun down and the supernatant aliquoted into 
500 pi batches and frozen at -80 “ C.
Enzymatic Synthesis o f Octyl 2-acetamido-2-deoxy-4-Ofp~D-galactopyranosyl)-p-D- 
glucopyranoside (31)
A suspension of octyl 2-acetamido-2-deoxy-p-D-glucopyianoside (7) (60 mg,
O.lSmmol) in HEPES buffer (6 cm \ 20 mM HEPES, 20 mM MnClj containing 0.2% 
bovine serum albumin) was sonicated for 15 mins. AUcaline phosphatase (40 pi, 10 U), 
UDP-glucose-4-epimerase (200 pi, 1 U), bovine P-l,4-GalT (EC 2.4.1.22) (200 pi, 2 U) 
and UDP-glucose (120 mg, 0.36 mmol) were added and the gel was incubated at 37 “ C until 
t.l.c, (CHCl^/MeOH/H^O, 10:10:3) indicated the no change in the reaction (24 h). Water
t
was added and the mixture was purified by reverse phase chromatography on Cjg SepPalc 
cartridges. Excess octyl GlcNAc (7) was removed by passage through lipophilic Sephadex 
LH20 using MeOH as an eluent. Concentiation yielded a white solid (50mg, 56%) with 
analytical data identical to that obtained previously.
General Procedure for Sialylation Reactions
Octyl LacNAc derivatives (9 pmol) were dissolved in TRIS buffer (600 pi, 50 mM 
Trizma base at pH 7 containing 0.02% NaNj) and PNP-NeuAc (18 pmol) and transsialidase 
(50 pi of a standard preparation) were added. The assay was incubated at 25 “ C until t.l.c. 
(CHClg/MeOH/HgO, 10:10:3) indicated the reaction to be complete(96 h). The assay was 
diluted with HgO (1 cm^) and loaded onto a QAE-Sephadex (anionic) column, eluted with
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NaCl (1 M) directly onto a C,s SepPak cartridge, washed with water and eluted with 
MeOH. The MeOH eluent was loaded onto a lipophilic Sephadex LH20 column and the 
fractions containing the sialylated compound were eoncentrated to dryness yielding a white 
solid (4-6 pmol, 44-71%).
The following compounds were prepared using the procedure outlined above:
Octyl 2-acetamido-2-deoxy-4-0-[-(a-2,3’-5-acetamido-3,5-dideoxy-D-glycero-a-galacto- 
non-2-ulopyranosyl)-j3-D-galactopyranosyl]-l3-D-glucopyranoside (36)
ÔH (DjO), 0.6-1.5 (15 H, 3xm, octyl H), 1.8 (1 H, t, / 3-„ 4.3 and 12.2Hz, 3"- 
Ha), 2.05 (6 H, s, Na4c), 2.80 (1 H, dd, and Jj.,,4.4 .2Hz, 3"-He), 3.5-3.95 (28 H, m),
4.01 (1 H, dd, ^ 4,11 .6 and <2Hz, 6b-H), 4.38 (1 H, d,  ^7.8Hz, 1-H), 4.44 (1 H, d, 
7.9Hz, I ’-H); ES-MS: Calcd for [CjjHssOuN,] 786.0 obs: m/z 785.7 (M-1).
Octyl 2-acetamido-2-deoxy-4-0-[-(a-2,3 '-5-acetamido-3,S-dideoxy-D-glycero-a-galacto- 
non-2-ulopyranosyl)-/3-D-galactopyranosyl]-3-Osulfonato-fi-D-glucopyranoside (37)
5h (D;0), 0.6-1.5 (15 H, 3xm, octyl H), 1.8 (1 H, t, 4.6 and y;.,4.12.0Hz, 3"-
Ha), 2.01 (3 H, s, N afc), 2.05 (3 H, s, NH4c), 2.79 (1 H, dd, and ..^ ,,.4.4.6Hz, 3"-He), 
3.5-3.S (13 H, m), 3.8-4.0 (13 H, m), 4.1 (1 H, d d ,^ *  12.0 and ys,a,4.6Hz, 6b-H), 4.5(1 
H, t, / 3,4 and 10.4Hz, 3-fl), 4.52 (1 H, d, J,,, 7.5Hz, 1-H), 4.64 (1 H, d, 8.1Hz, T- 
H); 5c (DjO), 11.5, 20.1, 20.4, 23.1, 26.4, 26.6 (2xC), 29.2, 37.7, 49.7, 52.7, 58.0, 59.0,
60.6, 65.8, 66.2, 66.4, 67.4, 68.7, 69.8, 71.0, 73.0, 73.1, 74.0, 74.3, 77.4, 97.8, 98.5, 101.3,
102.5, 171.8 (C=0), 172.4 (0=0), 173.0 (0=0); ES-MS: Calcd for [CjjHsjO^jN^S] 867.6, 
obs m/z 887.1 (M-t-Na-1), 865.1 (M-1), 432.5 (M" ).
Octyl 2-acetamido-2-deoxy-4-0-[-(a-2,3'-5-acetamido-3,5-dideoxy-D-glycero-a-galacto- 
non-2-ulopyranosyl)-f}-D-galactopyranosyl]-3-0-phosphonato-^D-glucopyranoside (38) 
8„ (D3O), 0.6-1.5 (15 H, 3xm, octyl H), 1.79 (1 H, t, 12.0 and J 3. .412.1Hz, 3"-
Ha), 2.03 (6 H, s, 2xNHXc), 2.76 (1 H, dd, y j . , , a n d 4 . 6 H z ,  3"-He), 3.5-3.7 (13 H, m), 
3.7-4.0 (12 H, m), 4.04 (1 H, dd, y„,<2  and 11.6Hz, 6a-H), 4.1 (1 H, dd, and 7;^,
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3.3Hz, 6h-H), 4.21 (1 H, dd, ^  and ^ ,4 9.8Hz, 3-/0, 4.56 (1 H, d, 8.5Hz, 1-70,4.57 (1 
H, d, Jr.2' 8.6Hz, r - /0 ;  ÔC (D2O), 11.5,20.1 (2xC), 20.6, 23.1, 26.4, 26.6 (2xC), 29.2, 37.8,
49.7, 53.3, 58.2, 59.0, 60.6, 65.6, 66.2, 66.4, 67.2, 68.5, 69.8, 71.0, 73.4 (2xC), 73.7, 97.8,
99.0.101.166.7.171.9.172.6 (C=0), 173.0 (C=0), 173.9 (C=0); 5p (D^O), 0 .5 .
Octyl 2-acetamido-2-deoxy-4-0-[-(a-2,3‘-5-acetamido-3,5~dideoxy-D-glycero-a-galacto- 
non-2~ulopyranosyl)~P-D-galactopyranosyl]-6-0'-sulfonato-p~D-glucopyranoside (39)
Ôh (D2O), 0.6-1.5 (15 H, 3xm, octyl H), 1.76 (1 H, t, 12.1 and 12.2Hz, 3"- 
7/a), 1.99 (6 H, s, 2xNKMc), 2.71 (1 H, dd, and J 3«„4»4 .5Hz, 3"-//e), 3.4-4.0 (26 H, 
m), 4.08 (1 H, dd, Js.6a<2 andJ^^t 12.1Hz, 6a-/0, 4.28 (1 H, dd, Js,eb'^2 and 4.5
(1 H, d, 2 7.6Hz, 1-/0, 4.56 (1 H, d, 2.7.6Hz, I'-H); 0  ^(D20), 11.5, 20.1 (2xC), 20.3,
23.1, 26.4, 26.6, 29.2, 37.6, 49.8, 53.2, 59.1, 60.6, 64.4, 65.5, 66.1, 66.5, 67.5, 68.7, 69.5, 
70.4, 70.6, 70.9, 73.1, 73.4, 75.3, 97.8, 99.2, 100.2, 172.0 (C=0), 172.4 (0=0), 173.0 
(C=0).
Octyl 2-acetamido-2-deoxy-3~0-(a-D-fucopyranosyl)-4-0-[-(a-2,3 ‘-5-acetamido-3,5- 
dideoxy-D-glycero-a-galacto-non-2-ulopyranosyl)-/3-D-galactopyranosyl]-j3-D- 
glucopyranoside (octyl sialyl Lewis x) (40)
Sialyl octyl LacNAc (36) (2 mg, 2.5 pmol) was dissolved in assay buffer (200 pi,
20 mM HEPES, pH 7 containing 20 mM MnClj and 0.2% bovine serum albumin) and the 
following components were added; GDP-Fuc (1 eq per day for 4 days), enzyme (400 pi, 
semi-pure human milk a-l,3/4-FucT) and alkaline phosphatase (20 pi, 5U); ES-MS: Calcd 
for [C3A A 3N2] 933.5, obs m/z 931.9 (M-1), 785.6 (M-Fuc).
Octyl 2-acetamido-2~deoxy-3-0-(a-D-fucopyranosyl)-4-0-(0-D-galactopyranosyl)-/3-D- 
glucopyranoside (octyl Lewis x) (41)
Sialyl octyl Le’' (40) (1.5 mg, 1.8pmol) was dissolved in HEPES buffer (100 mM, 
pH 7.0) and neuraminidase type V (isolated from Clostridium perfringens, purchased from 
Sigma) (lU) was added. The assay was incubated at 37 “ C for 2 h quenched with water and
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purified by standard anion exchange and SepPalc chromatography. ES-MS: Calcd for 
[CjgHsiOisN] 641.5, obs m/z 639.9 (M-1).
General Procedure for a-l,3-FucT Kinetics Experiments
Acceptor kinetic assays contained the following components, assay buffer (2 pi, 20 
mM HEPES, pH 7 containing 20 mM MnClj and 0.2% bovine serum albumin), GDP-Fuc 
(50 pM, in HgO) and ^H GDP-Fuc* (0.5 pi) enzyme and/or water to 20 pi final volume 
with 5-6 acceptor concentrations (in duplicate) ranging from 0.2-2 times for each 
acceptor. After incubations at 37 ° C for 10-180 mins, the assays were quenched with water 
(0.5 cm^) and applied to C,8 SepPak cartridges previously washed with methanol and 
equilibrated with water. The cartridges were washed with H^O (35 cm^) and radiolabelled 
products eluted with MeOH (4 cm^) directly into scintillation vials. Samples were counted 
in a Minaxi Tri-Carb 4000 scintillation counter after the addition of Opti-phase Hi-Safe 
liquid scintillation coclctail (Wallac) (9 cm^).
General Procedure for f~l,4-GalT Kinetic Experiment
Acceptor kinetic assays contained the following components, assay buffer (2 pi, 20 
mM HEPES, 20 mM MnClj containing 0.2% bovine serum albumin), UDP-Gal (10 pM) 
and ^H UDP-Gal (0.5 pi)® enzyme and/or water to 100 pi final volume with 3 acceptor 
concentrations. After incubations at 37 °C for 30 mins, the assays were quenched with 
EDTA (850 pi, 10 mM) and applied to SepPak cartridges previously washed with 
methanol and equilibrated with water. The cartridges were washed with HgO (10 cm^) and 
radiolabelled products eluted with MeOH (4 cm^) directly into scintillation vials. Samples 
were counted in a Minaxi Tri-Carb 4000 scintillation counter after the addition of Opti- 
phase Hi-Safe liquid scintillation cocktail (Wallac) (9 cm^).
* GDP-Fucose [Fucose-2-^H(N)], 574 GBq/mmol; purchased from NEN
 ^ UDP-Galactose UDP-[6-^H]-Gal was purchased from Amersham and had a specific activity of 566 
GBq/mmol.
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A Representative Example
The calculation of the and values for the substrate octyl LacNAc 6-sulfate
(17) with a-l,3-FucT VI is shown. Table 5-7 shows the substrate concentrations used and 
the counts per minute (c.p.m.) obtained from the scintillation counter. A blank assay 
containing no acceptor gave the c.p.m. for the background (30-90 c.p.m.) and this value was 
subtracted from the c.p.m. for all other acceptor concentrations.
Substrate Concentration Counts per
(HM) minnte
5.00 2880
2674
2.5 2553
2629
1.25 2152
2072
0.625 1452
1457
0.312 906
884
0.156 541
517
Table 5-7: Raw Data from Octyl LacNAc 6-siilfate Experiment
with a-l,3-FncT VI
A graph of substrate concentration versus rate was plotted using Enzfitter software (version
1.05, published by Elsevier-Biosoft, 1987) and is shown in Figure 5-8.
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Figure 5-8: Plot of [§] versus Rate (counts per minute in 30 mins)
The Lineweaver-Burk double reciprocal plot is shown in Figure 5-9.
1 ,4 0 -
5.00
Figure 5-9: Lineweaver-Burk Plot ,
From the non-linear regression plot, the Km was calculated to be O.BSpM and the Vmax to be 
3940 pmol/min/mg. The errors on calculating these values were 5%. Only the Km and Vmax 
data will be presented for all other calculations. Lineweaver-Burk plots for all experiments 
are given in Appendix 2.
Procedure for Radiochemical T.L.C. Analysis
Radiolabelled assay was carried out as described for acceptor kinetic assays. After 
incubation (3 h) and SepPalc purification, the product was eluted from the SepPak with 
methanol (4 cm^). 10% of the methanol eluent was diluted with scintillation cocktail and 
counted as described for acceptor Icinetic assays. The remainder of the methanol eluent was 
concentrated to dryness and a known amount of methanol was added. An aliquot of this
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sample was loaded onto a t.l.c. plate containing markers of octyl Lewis x (4Î) and 
chemically synthesized fiicosylated octyl LacNAc phosphate diester (Figure 5-4). The t.l.c. 
was developed (Me0H/CHCl3/H20 10:10:3) and the silica was removed from the plate in 1 
cm  ^ strips. Methanol was added to each silica sample and the suspension was vortexed 
thoroughly and centrifuged. The supernatant was removed and placed directly into a 
scintillation vial. This process was repeated three times and the combined MeOH 
supernatants were diluted with scintillation coclctail and counted as described for acceptor 
kinetic assays.
Chemical Synthesis o f Fucosylated Octyl LacNAc Phosphate Diester
The synthesis of the fucose diester linkage to the 3-O-phosphate derivative of octyl 
LacNAc (16) was carried out by Taketo Uchiyama in the laboratories of Prof. Ole 
Hindsgaul at the University of Alberta. Scheme 5-2 shows the overall synthesis of the 
desired compound. The general procedure for this reaction can be found in ref. [11].
OTM8_lOTMS TMS-I(leq)
OH TMS-Cl, py CHgCh
 ^ OTMS
NHAc
OH
HO o . _/° NHAc
O-octyl
O-octyl
in situ
i. coupling with phosphate
ii. BujNF
iii. DEAE column 
chromatography
iv. Dowex 50W (Na^
Scheme 5-2: Chemical Synthesis of Phosphate Diester Trisaccharide
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Preparation o f n-BuJSf Salt o f (16)
Na salt of compound (16) (1.3 mg, 0.021 mmol) was dissolved in HgO (1 cm^) and 
the solution was passed through Dowex SOW (ff , 200-400 mesh, 0.75 cm x 3 cm) and 
fractions containing free acid were titrated using aqueous n-B\x^lA(OH) (40%) to pH 7. The 
resulting solution was fr eeze dried to yield the tiltle compound as a white powder.
Preparation o f per-TMS-L-fucopyranose
To a solution of L-fiicose (16 mg, 0.1 mmol) in pyridine (0,5 cm^), 
chlorotrimethylsilane (76 pi) was added at 0 “ C. After I h, «-pentane (6 cm^) was added to 
the reaction mixture which was then extracted with cold HgO (5x1 cm^). The organic layer 
was dried over NagSO  ^and solvent was concentrated to dryness to yield the title compound 
(45 mg, 98%).
Preparation o f fucose-phosphate diester link to octyl LacNAc
To a solution of per-TMS-L-fuc (9.5 mg, 0.021 mmol) in CHgCl  ^ (0.3 cm^), 
iodotrimethylsilane (3 pi, 0.021 mmol) was added at r.t. and the reaction mixture was 
stirred for 30 mins. The reaction mixture was then added to a mixture of (16) (m-Bu^N salt,
0.02 mmol) in dry CH^Cl  ^ (2 cm^) and stirred for 3 h. A solution of «-BuN^F (1.0 M, in 
THF, 63 pi) was added to the reaction mixture and stirred for 1 h. The mixture was 
concentrated to dryness and the residue was redissolved in H^O (10 cm^) then applied to 
DEAE Sephadex (1.5 cm x 12 cm, packed in 20 mM NH4HCO3) and eluted using a linear 
gradient from 20 mM to 400 mM NH4HCO3 (1 cm  ^ / min, 6 cm  ^ for each fraction). The 
appropriate fractions were pooled and concentrated to ~ 10 cm  ^(pH=8 to 8.5). Dowex 50W 
X8 (H ,^ 200-400 mesh) was then added slowly until neutralisation had occurred. The resin 
was removed by filtration and the filtrated was passed thi*ough a column of Dowex 50W X8 
(Na\ 20-50 mesh, 1.5 cm x 5 cm) with water. The eluent was freeze dried as a white 
powder to give an anomeric mixture of the title compound (4 mg, 40%).
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The target molecules shown in Figure 6-1 Figure 6-2 were synthesized in 
reasonable to high yields. The sialylated compounds (Figure 6-3) were prepared using a 
chemo-enzymatic method using ^ra«5-sialidase (T. cruzi).
Figure 6-2: Octyl Gal-p-ljS-GIcNAc Derivatives
NHAc
AcHN"  ^ OH
O-octyl
36. X = OH Y = OH
37. X = OH Y =0803'
38. X = OH Y = 0P03^'
39. X = OSO3" Y=OH
HO1 f  NHAc 
OH \
X
31. X = OH Y = O H
15. X  = OH Y = O SO 3 '
16. X = OH Y  = OPOs^"
17. X = O SO 3 " Y = OH 
19. X = 0 P 0 3 ^ ' Y = OH
18. X = O SO 3 ' Y = O 8 O3 " 
aO. X = 0 P 0 3 ^ ' Y  = 0 P 0 3 ^ '
Figure 6-1: Octyl LacNAc Derivatives
HO
O -octyl
OH NHAc
32. X = OH Y = OH
25. X = OH Y = O 8 O3 "
26. X = OH Y = OPOs^'
27. X = O SO 3 " Y = OH
28. X = OPOs^" Y = OH
29. X  = O SO 3 " Y = 0 0 0 3 '
30 . X = 0 P 0 3 ^ ' Y  = OPOs^"
Figure 6-3: Sialylated Octyl LacNAc Derivatives
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These molecules were screened as potential acceptor substrates for five recombinant a-1,3- 
FucT’s and semi-pure Lewis a-l,3/4-FucT (human milk). It is clear from Tables 5-1 - 5-6 
(Chapter 5) that the measured values vary dramatically firom enzyme to enzyme. 
Similar observations have been made about recombinant a-l,3-FucTs by deVries and co­
workers [1]. It is conceivable that this arises due to the presence of only partially active 
enzyme as a result of, for instance, misfolding of some of the recombinant enzymes. It is 
possible, of course, that the various a-l,3-FucTs simply have very different substrate 
specificities and that we have been looldng at inappropriate substrates with some of the 
enzymes. The relative /K^ data quoted can, however, be used to identify trends in the 
acceptor substrate specificities of various a-l,3-FucTs. Table 6-1 shows relative V^JK^ 
data for all the a-l,3-FucT enzymes and all the substrates.
The results shown for a-l,3-FucT V conflict with previously reported data. Murray 
and co-workers [2] reported Gal-p-1,4-GlcNAc-OR (where R= methoxycarbonyloct-l-yl) 
to have a of 170 pM for recombinant a-l,3-FucT V. However, for the similar substrate 
Gal-p-1,4-GlcNAc-OR (where R= octyl) we found the to be greater than 7 mM and 
therefore could not be calculated accurately due to problems of insolubility of the substrate. 
This data does agree, however, with the published work of deVries and co-workers [1] 
whom reported Gal-P~l,4-GlcNAc-OR (where R= methoxycarbonyloct-l-yl) to have a 
of>10mM.
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Enzyme/
Substrate
m ry V VI v n milk
enzyme
Type I
Gal-P-l,3-GlcNAc-0R (32) 100 ND ND - ND 85
4-0-sulfate (25) - ND ND - ND 5
4-0-phosphate (26) - ND ND - ND 2
6-0-sulfate (27) 46 ND ND - ND ND
6-O-phosphate (28) 144 ND ND - ND ND
T y p e ll
Gal-p-l,4-GlcNAc-OR (31) - 100 - 100 100 100
3-O-sulfate (IS) - “ 46 - 11
3-O-phosphate (16) - " - 7 - 9
6-O-sulfate (17) 2 202 84 2126 - ND
6-O-phosphate (19) 11 115 37 2245 - ND
3,6-di-O-sulfate (18) - - - 11 - ND
3,6-di-O-phosphate (20) - - - 8 - ND
Type ÏI sialylated
Gal-p-l,4-GlcNAc-0R (36) - - 100 555 14 ND
3-O-sulfate (37) - - 7 30 58 ND
3-O-phosphate (38) - - - 6 - ND
6-O-sulfate (39) 1 - 108 1150 888 ND
Table 6-1: Relative Data for ail a-l^-FucTs Tested
R= -(CH2)?CH3 (octyl), ND= not determined
An interesting observation was the decrease in /C ,^ relative to the parent 
unsubstituted compound, measured for compounds containing a sulfate group at the 6- 
position of octyl LacNAc (17) or octyl Gal-p-l,3-GlcNAc (27). This enhancement in 
binding affinity of the 6-O-sulfate derivatives was observed across all the a~l,3-FucT’s 
examined with the exception of a-l,3-FucT IV (which had similar to the unsubstituted 
compound). According to Palcic and co-workers [3] the 6-OH was thought to be orientated 
away from the protein into free solution. If this was the case then the presence of a sulfate
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group at the 6-position would be expected to have little or no effect on the binding ability of 
the substrate, 6-Sulfo Le’^ is a natural product [4], so perhaps the 6-O-sulfate is simply more 
related to the true substrate for a-l,3-FucT. This argument would require only one a-1,3- 
FucT to be affected by the substitution of a sulfate group at the 6-OH. From the results 
obtained the binding and turnover of the 6-O-sulfate with a-l,3-FucT VI has a much 
enhanced effect, so perhaps a-l,3-FucT VI is involved in the biosynthesis of 6-sulfo Lewis 
X [4]. However, an effect on binding was observed for most of the a-l,3-FucT’s examined 
and this effect was also observed for type I chains (6-0-sulfonato Gal-p-1,3-(a-1,4-Fuc)- 
GlcNAc is not a reported natural product). A reason for this may be that the presence of an 
anionic group increases the solubility of the substrates allowing better availability of the 
substrate in the enzyme active site.
For enzymes tolerating a 3’-sialic acid moiety, a similar pattern was observed with 
the 6-O-sulfate sialylated derivative (39), although the decrease in was not as dramatic 
as for the non-sialylated substrates. This may be due to the presence of too great an overall 
charge on the molecules which may result in a tight solvation of the molecule creating 
steric buUc and thus preventing tight binding of the substrate to the enzyme active site.
In agreement with the unpublished work of Palcic and co-workers, it was also 
observed that for a-l,3/4-FucT (milk) and a-l,3-FucT VI the 3-O-sulfate (15) and 3-O- 
phosphate (16) compounds did act as acceptor substiates with and values similar to 
those of the parent compounds. For a-l,3-FucT V, VI and VII, the sialylated compound 
containing a sulfate group at position 3 (37) were also observed to be substrates for the 
enzymes with similar kinetic parameters to sialyl octyl LacNAc (31). As this is the site of 
glycosylation for a-l,3-FucT, the assumed product must be a sulfate or phosphate diester 
linkage to fucose (Figure 6-4).
120
HO OH
OH
PHHO NHAc
O-octylHO
OH
OH
Figure 6-4: Fucosylated Phosphate Diester Product
Experiments were carried out to identify the product of the fucosylation reaction. 
Preliminary results show that the product of the reaction may be the chemically stable 
phosphate diester shown in Figure 6-4. The ability for some a-l,3-FucT’s to fucosylate a 
phosphate group suggests that the model proposed by Lowary and Hindsgaul [5] involving 
a general base activation of the hydroxyl group to be glycosylated by the enzyme (Figure 
6-5) does not tell the whole story.
OR
Figure 6-S: Geueral Base Mechanism for Activation of Hydroxyl Group to be
Glycosylated [5]
However, these results would hold for a model where the manganese cation is involved in 
binding the hydroxyl group to be glycosylated (Figure 6-6) as proposed in Chapter 1. The 
coordination of the manganese cation may have the effect of reducing the pKa of the 
hydroxyl gioup of the acceptor substrate and thus increase the nucleophilicity of the oxygen 
to attack the donor. In the case where the hydroxyl group to be glycosylated of the acceptor 
molecule is replaced by an anionic gioup such as a sulfate or phosphate, coordination to the 
Mn^  ^should still occur and thus will still be an effective substrate for a-l,3-FucT.
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OR
Figure 6»6; Model Proposed for Activation of 
Hydroxyl Group to be Glycosylated by
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6.2 Ffftwrg FForÆ
6.2.1 Phosphate ©tester Vérification
The work carried out during this study gave preliminary results suggesting that the 
product of the reaction with octyl LacNAc 3-O-phosphate and a-l,3-FucT VI was a 
fucosylated octyl LacNAc phosphate diester derivative. However in order to confirm the 
structure of this product it would be necessary to characterize the product by n,m.r. 
spectroscopy. There should be a distinct change in the 6p shift between a phosphate 
monoester and a phosphate diester and a change in shift should also be observed for the 
H-1 signal of fucose. The assay used to attempt this biotransformation used allcaline 
phosphatase to degrade the excess GDP forming in the reaction. However this resulted in 
cleavage of the phosphate from the acceptor substrate. To synthesize sufficient phosphate 
diester product enzymatically, therefore, will require a new assay system with a different 
method for removing excess GDP forming during the reaction. A simple solution to this 
would be to quench, work up and repeat the assay daily to prevent build up of GDP.
6.2.2 Verification for the Proposed Model Involving Coordination to the
Acceptor Substrate
In an attempt to verify the proposed model for Mn^  ^coordination shown in Figure 
6-6 at least two approaches need to be adopted. The first approach would involve synthesis 
of thiol and thio-phosphate substrates as these substrates should have a greater affinity with 
Mn^  ^ than the unsubstituted or sulfated and phosphorylated compounds. The second 
approach would be to alter the metal cation, replacing Mn^  ^with Mg^ ,^ Ca^^and Co^ .^ Full 
Idnetics with all the substrates (sulfate, phosphate, thiol and thiophosphates) and all the 
metal cations may give support to the proposed model for coordination of the metal cation. 
If the metal cation is involved in coordinating the acceptor hydroxyl being glycosylated, 
then the sulfur containing compounds should be good substrates with thiophilic metals, for 
example Mn^ .^ Compounds containing sulfate, phosphate or a free hydroxyl ought to have a 
greater affinity for metals such as Mg^ .^ a-l,3-FucT VI was the only enzyme for which the
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3-O-sulfate and phosphate derivatives were good substrates. Perhaps the model proposed 
can only be applied to this particular enzyme. Therefore, it would be important to carry out 
all experiments with all a-l,3-FucT enzymes to identify whether the metal cation is binding 
to the hydroxyl group being glycosylated or to an alternative site on the acceptor molecule. 
This in turn could prove useful in the development of tissue-specific a-l,3-FucT inhibitors 
for therapeutic uses.
It would also be appropriate to conduct further studies with a-l,3-FucT VI as this 
appears to be the most active enzyme we have access to and also has the lowest 
observed for any substrate with a-l,3-FucT. Assuming therefore that this is a good
starting point for making photoaffinity labelled substrates which bind tightly to the enzyme 
and will yield information about the binding site of the enzyme.
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